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Eps15 and Eps15L1 are endocytic adaptor proteins involved in both clathrin-mediated and 
clathrin-independent endocytosis of receptor tyrosine kinases. Eps15/Eps15L1 double 
knockout mice are embryonic lethal and display a Notch loss-of-function phenotype, 
accompanied by downregulation of Notch target genes.  
The Notch pathway is an evolutionary conserved signal transduction pathway that 
regulates multiple aspects of the development of multicellular organisms. Notch signaling 
activation requires direct contact between a signal-sending cell, expressing the ligand, and 
a signal-receiving cell, expressing the receptor. Both Notch ligands and receptors are 
transmembrane proteins, tightly regulated by endocytosis and membrane trafficking. 
Given these premises, the overall aim of this thesis was to understand whether Eps15 and 
Eps15L1 have a direct role in the regulation of Notch signaling, and, if so, whether this 
regulation takes place in the signal-receiving cell or in the signal-sending cell. Our final 
goal was to understand the molecular mechanisms by which Eps15 and Eps15L1 affect 
Notch signaling. 
To investigate the role of Eps15 and Eps15L1 in Notch signaling, we set-up a co-culture 
model system composed of the signal-sending cell OP9-Dll1 that overexpresses the ligand 
Dll1, and the signal-receiving cell C2C12-Notch1 that overexpresses the receptor Notch1. 
To assess the role of Eps15 and Eps15L1 in Notch signaling regulation, we developed an 
in vitro Notch transactivation reporter assay based on our co-culture model system. We 
observed no reduction in Notch activity after knockdown (KD) of Eps15 or Eps15L1 in the 
signal-receiving cell, indicating that the two proteins do not have a role in the regulation of 
Notch receptors. However, when we performed KD of Eps15 and/or Eps15L1 in the 
signal-sending cell, we observed a 40-50% reduction in Notch activity. This reduction was 
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observed for all the Notch ligands tested, Dll1, Dll4, Jag1 and Jag2, indicating that Eps15 
and Eps15L1 have a general role in the modulation of Notch ligand activity/signaling.  
Since Eps15 and Eps15L1 are known to act in combination with Epsin, a fundamental 
regulator of Notch ligand internalization, we investigated whether removal of Eps15 and 
Eps15L1 from the signal-sending cell affected the early steps of Dll1 endocytosis. To do so, 
we set-up a Dll1 internalization assay to measure induced or constitutive Dll1 endocytosis. 
Using this assay, we observed a strong reduction in Dll1 endocytosis following KD of 
known endocytic regulators of Notch ligands, Epsin and Mindbomb1. However, we did not 
detect any alterations in Dll1 internalization after KD of Eps15, Eps15L1 or both Eps15 
and Eps15L1, indicating that the two proteins do not participate in the regulation of the 
early steps of Notch ligand endocytosis, both induced and constitutive. 
Eps15 and Eps15L1 have also been implicated in endocytic recycling. Therefore, we asked 
whether a recycling function of Eps15/Esp15L1 could be involved in Notch ligand 
regulation. We attempted to assess Dll1 recycling in OP9-Dll1 cells, however, results 
suggested that Dll1 does not undergo significant recycling in our experimental conditions, 
therefore a change of strategy will be necessary. We also assessed Dll1 localization in 
plasma membrane lipid rafts following KD of Eps15 and Eps15L1, but did not score any 
change in ligand membrane localization.  
In conclusion, we showed that Eps15 and Eps15L1 are key regulators of Notch ligands in 
the signal-sending cell. However, in contrast to their known role as endocytic adaptors, the 
two proteins do not appear to be involved in the early steps of Dll1 endocytosis. Given that 
Eps15 and Eps15L1 have been implicated in other pathways and cellular processes, such as 
recycling, secretion, degradation, cell-matrix adhesion and cell-cell connection, it is 
possible that Eps15/Esp15L1 might mediate Notch ligand regulation through one of these 
other pathways. However, the precise molecular mechanisms by which Eps15 and 
Eps15L1 regulate Dll1 activity remain to be defined, and will be the focus of future studies. 
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1.1 Role of endocytosis in the cell 
The plasma membrane is the surface through which the cell mediates molecular exchanges 
and communications with other cells and the external environment. To do this, the cell 
takes advantage of mechanisms that mobilize large portions of the plasma membrane, 
namely endocytosis and exocytosis. Endocytosis mediates the internalization of nutrients 
and macromolecules contained in the extracellular fluid (Doherty & McMahon, 2009). In 
addition, endocytosis contributes to the production and renewal of cell membranes through 
the internalization of lipids and membrane proteins. Through the opposed process of 
exocytosis, the cell is able to bring newly synthesized proteins and lipids to the plasma 
membrane, and expel waste and toxic substances from the cytoplasm (Conner & Schmid, 
2003; Doherty & McMahon, 2009). However, the role of endocytosis is not only limited to 
nutrient uptake and interactions with the extracellular environment. Increasing evidence 
indicates that endocytosis and endocytic proteins are also involved in the regulation of 
diverse cellular processes including: i) signal transduction, through regulating the assembly 
of signaling platforms at the plasma membrane; ii) cell polarity, through asymmetrical 
distribution of membranes and signaling molecules; iii) motility, through the continuous 
endocytic reorganization of the plasma membrane, which is essential for changes in cell 
shape; iv) cell division; v) transcription (Scita & Di Fiore, 2010; Sigismund et al., 2012). 
For the latter two processes, although there is evidence of an involvement of endocytic 
 16 
proteins, this involvement does not seem to be connected to the plasma membrane or the 
process of endocytosis itself (Scita & Di Fiore, 2010; Sigismund, et al., 2012). 
Cells possess several endocytic routes that differ mainly in the characteristics of the 
transported cargo and the protein machinery involved in cargo uptake. These routes can be 
divided into two principal categories: phagocytosis and pinocytosis (Figure 1.1). 
Phagocytosis mediates the uptake of large particles, such as whole microorganisms or cell 
debris, through the formation of large membrane expansions. The particles are then 
directed to the lysosome for degradation by lysosomal enzymes (Figure 1.1). Pinocytosis, 
instead, mediates the uptake of smaller cargos and involves less extensive modifications of 
the plasma membrane. Pinocytosis is in turn divided into: i) macropinocytosis, which 
mediates the unspecific uptake of extracellular fluids; ii) clathrin-dependent endocytosis, 
which mediates entry into the cell via clathrin coated vesicles; iii) clathrin-independent 
endocytosis, which includes all endocytic routes that do not depend on the coating protein 






Figure 1.1 Endocytic routes of entry into the cell. 
Large particles and microorganisms are internalized through phagocytosis, while fluids are brought 
into the cell via macropinocytosis. Both mechanisms involve actin remodeling of the plasma 
membrane and the formation of large vesicles. The majority of solutes and molecules are 
internalized and conveyed to the endosomal compartment through clathrin-coated or caveolin-
coated vesicles. Internalization mechanisms independent of both clathrin and caveolin are also 
present [adapted from: (Mayor & Pagano, 2007)]. 
 
1.2 Clathrin-mediated endocytosis 
Clathrin-mediated endocytosis (CME), also referred to as receptor-mediated endocytosis, 
is a highly specific process by which transmembrane receptors present in the plasma 
membrane, together with their ligands, are internalized into the cell via ‘coated pits’, i.e., 
vesicles formed by the cytosolic coat protein clathrin. CME is the main endocytic route 
responsible for the internalization of receptor tyrosine kinases, G protein-coupled receptors 
and transferrin (TfR) receptors (Conner & Schmid, 2003; Doherty & McMahon, 2009; 
McMahon & Boucrot, 2011). 
Phagocytosis Pinocytosis 
Macropinocytosis Clathrin  
dependent  
endocytosis 









Clathrin is organized in trimers, named triskelia; each triskelion is composed of three 
clathrin heavy chains, with a molecular weight of ≈ 180 kD each, and three light chains, 
with a molecular weight of ≈ 35 kD each. When triskelia assemble in solution, they create 
a lattice cage composed of hexagons and pentagons that gives shape to the rounded 
vesicles (Faini et al., 2013). In vivo, several adaptor proteins help to coordinate clathrin 
nucleation, vesicle formation and cargo recruitment at specialized sites in the plasma 
membrane. Clathrin nucleation and subsequent polymerization allows the deformation of 
the plasma membrane and the establishment the vesicle neck. Detachment of clathrin-
coated vesicles from the plasma membrane requires the activity of the GTPase dynamin. 
dynamin forms a helical polymer around the vesicle neck and allows the release of the 
vesicle in the cytoplasm following GTP hydrolysis. After vesicle release, clathrin detaches 
from the surface, allowing vesicle fusion with the intracellular compartment of destination 
(Figure 1.2) (Conner & Schmid, 2003; Doherty & McMahon, 2009; McMahon & Boucrot, 
2011). 
A great variety of adaptor proteins can also play a role during the formation of clathrin-
coated pits, to further optimize the process. Accessory proteins may participate in vesicle 
formation, by helping with cargo recruitment, in membrane deformation, or they may 
perform a scaffold function, acting as bridge to connect components participating in the 
endocytic process (Reider & Wendland, 2011). The adaptor protein 2 (AP2) complex, for 
example, is the main component of clathrin-coated pits, after clathrin itself. AP2 is able to 
interact with cargo proteins, lipids, clathrin and other endocytic accessory proteins at the 
site of internalization. Other endocytic accessory proteins that also participate in CME, for 
instance, include: i) Intersectin that binds to components of the endocytic machinery, as 
well as elements of the actin cytoskeleton; ii) epidermal growth factor receptor substrate 15 
(Eps15), a scaffold protein that promotes clustering of AP2; iii) Epsin, an Eps15 binding 
partner that, in addition to its role of anchoring the cargo to clathrin, can directly bind 
 19 
phosphatidylinositol lipids and help with membrane deformation through the insertion of 




Clathrin triskelia polymerization allows invagination of the plasma membrane and formation of the 
vesicle neck. Release of the vesicle in the cytoplasm is mediated by dynamin, which forms a helical 
polymer around the vesicle neck. Clathrin is subsequently released from the vesicle and is recycled 
for another endocytic cycle [adapted from: (Doherty & McMahon, 2009)]. 
 
1.3 Clathrin-independent endocytosis 
All the endocytic routes that do not require vesicle coating by clathrin are classified as 
clathrin-independent endocytosis (CIE). Indeed, CIE is experimentally defined by 
insensitivity to clathrin removal. Moreover, CIE is sensitive to drugs that interfere with 
cholesterol organization in the membrane and disrupt lipid raft platforms. Consequently, 
the endocytic pathways that fall under this definition are highly heterogeneous and require 
different endocytic machinery (Conner & Schmid, 2003; Doherty & McMahon, 2009; 
Mayor & Pagano, 2007). CIE can be further classified on the basis of dynamin requirement. 
It was initially thought that dynamin, given its role in vesicle fission and release from the 
plasma membrane, would be involved in all forms of endocytosis. However, it was later 
discovered that some clathrin-independent pathways are also dynamin-independent 
(Damke et al., 1995; Guha et al., 2003; Mayor & Pagano, 2007; Wu et al., 2014). 
The most studied clathrin-independent, dynamin-dependent endocytic route is caveolae-
mediated endocytosis. Caveolae are invaginations of the plasma membrane enriched in 
Figure 1.2 Genesis of a clathrin coated pit 
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cholesterol and sphingolipids, and are characterized by the presence of caveolin proteins. 
Cargos internalized through caveolae are mainly proteins, proteins with lipid anchor, lipids 
and pathogens (Doherty & McMahon, 2009; Mayor & Pagano, 2007). A second clathrin-
independent, dynamin-dependent endocytic route employs the GTPase RhoA, and is 
responsible for internalization of the β chain of the interleukin 2 receptor. Classical 
examples of clathrin-independent, dynamin-independent endocytosis include 
internalization mediated by the GTPase CDC24, which is responsible for cholera toxin 
endocytosis, and endocytosis mediated by the GTPase ARF6, responsible for 
internalization of MHC class 1 proteins, β1 integrin and E-cadherin (Doherty & McMahon, 
2009; Mayor & Pagano, 2007). 
 
1.4 Endocytosis and signaling 
Endocytosis is one of the main mechanisms employed by eukaryotic cells to regulate 
signal transduction. Cells communicate with the extracellular environment, and with each 
other, through receptors localized on the plasma membrane. Receptors, following ligand-
dependent activation, are internalized and conveyed to different endosomal compartments. 
From there, they can be directed towards lysosomes for degradation, or back to the plasma 
membrane through a recycling pathway. In this way, endocytosis regulates signal 
transduction by controlling the number of available receptors on the plasma membrane 
(Figure 1.3) (Le Roy & Wrana, 2005; Sigismund, et al., 2012; Sorkin & von Zastrow, 
2009). 
The function of endocytosis, however, is not only limited to signal attenuation, but also 
encompasses signal modulation: duration, intensity, integration and spatial distribution of 
signals can all be regulated by endocytosis (Le Roy & Wrana, 2005; Sigismund, et al., 
2012; Sorkin & von Zastrow, 2009). A clear example of this type of endocytic regulation 
of signaling is provided by the epidermal growth factor receptor (EGFR). The EGFR is a 
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receptor tyrosine kinase involved in cell growth, survival, proliferation and differentiation. 
EGFR can be internalized through different endocytic routes, depending on the 
concentration of extracellular ligand. In the presence of low doses of EGF, EGFR is almost 
exclusively internalized through a clathrin-dependent route, which supports receptor 
recycling and prolonged signaling (Polo & Di Fiore, 2006; Sigismund et al., 2005). 
Conversely, at high EGF concentrations, the EGFR can also be internalized through a 
clathrin-independent pathway, which conveys part of the receptor towards degradation, 
thus avoiding excessive stimulation of the pathway (Polo & Di Fiore, 2006; Sigismund, et 
al., 2005). 
Another critical factor in signal transduction regulation by endocytosis, is the endosomal 
compartment. Endosomes can support signals that originate at the plasma membrane or 
they can generate their own signals, since they provide specific physical conditions, 
different from those of the plasma membrane (Sigismund, et al., 2012). For instance, the 
relatively small volume of endosomes can promote the association between ligands and 
receptors at lower concentrations. Endosomes are also enriched in certain lipids and 
proteins, which can provide a specialized scaffold environment, able to assemble specific 
signaling complexes. Moreover, endosomes possess an acidic pH in their lumen, which can 
favor specific chemical reactions, such as proteolysis of signaling molecules. Finally, 
endosomes are also connected to the cytoskeleton by microtubules, thus allowing signal 






Figure 1.3 Receptor signaling regulation by endocytosis. 
Receptors, activated by ligand, are mainly internalized through CME or CIE. Following 
internalization, receptors are directed to early endosomes, and from there to lysosomes for 
degradation, or back to the plasma membrane, through either slow or fast recycling pathways 
[adapted from: (Scita & Di Fiore, 2010)] 
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2. The endocytic adaptor proteins Eps15 and Eps15L1 
2.1 Eps15 and Eps15L1: structure and interactors 
The epidermal grow factor protein substrate 15 (Eps15) and the epidermal grow factor 
protein substrate 15-like1 (Eps15L1) proteins are endocytic adaptors that are involved in 
the regulation of receptor tyrosine kinase endocytosis, both CME and CIE. Eps15 is a 150 
KDa protein that is localized predominantly in the cytosol and was originally identified as 
a substrate of the EGFR (Fazioli et al., 1993). A subsequent screening of a mouse 
keratinocyte cDNA library, performed with the Eps15 homology domain (EH domain) as a 
probe, led to the identification of Eps15L1, a gene highly homologous to Eps15, whose 
product is approximately a 125 KDa protein (Wong et al., 1995) (Figure 1.4). 
Both Eps15 and Eps15L1 possess a modular structure in which different protein-protein 
interaction domains can be identified (Figure 1.4). Indeed, in the cell, Eps15 and Eps15L1 
act as endocytic adaptors, forming bridges between different proteins during the assembly 
of endocytic complexes in both CME and CIE. The N-terminal portion of the two proteins 
contains three EH domains that mediate binding to NPF (asparagine-proline-
phenylalanine)-containing endocytic proteins, such as Epsin, Numb, Hrb, Synaptojanin and 
Stonin (Chen et al., 1998; Doria et al., 1999; Haffner et al., 1997; Martina et al., 2001; Polo 
et al., 2003; Salcini et al., 1997). The central portion of the two proteins is occupied by an 
α-helical coiled-coil domain that can mediate homo- and hetero-dimerization of Eps15 and 
Eps15L1, as well as interactions with the endocytic adaptors Hrs and Intersectin (Bean et 
al., 2000; Sengar et al., 1999). In their C-terminal region, the two proteins contain several 
DPF (aspartic acid-proline-phenylalanine) tripeptide repeats that compose the AP2 binding 
site (Benmerah et al., 1996; Fazioli, et al., 1993; Iannolo et al., 1997). This site is 
immediately followed by a 14 amino acid sequence that mediates binding to adaptor 
protein 1 (AP1) (Chi et al., 2008; Kent et al., 2002), and two short sequences called UIM 
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(Ubiquitin interacting motif) domains that are responsible for binding to ubiquitinated 
proteins, as well as monoubiquitination of Eps15 and Eps15L1 (Polo et al., 2002). 
 
 
Figure 1.4 Modular structure of the endocytic adaptor proteins Eps15 and Eps15L1. 
Schematic representation of the modular structure of Eps15 and Eps15L1. Key domains are 
represented as follows: EH domains (orange), α-helix coiled-coil domain (green), DPF motifs 
(blue), AP1 binding site (purple) and UIM domains (red). 
 
 
2.2 Role of Eps15 and Eps15L1 in CME and CIE 
There is extensive evidence linking Eps15 and Eps15L1 to CME. Eps15 interacts with the 
alpha subunit of AP2 (Benmerah, et al., 1996; Benmerah et al., 1995; Benmerah et al., 
1998; Iannolo, et al., 1997), and the Eps15:AP2 complex, in turn, interacts with Epsin 
(Chen, et al., 1998) and the GTPase dynamin, which is responsible for vesicle pinch-off 
(Majumdar et al., 2006). Moreover, Eps15 colocalizes with active EGFR both at the 
plasma membrane and in different endocytic compartments (Torrisi et al., 1999). 
The importance of Eps15 in CME was experimentally demonstrated by several studies. In 
particular, overexpression of a mutant Eps15 lacking the second and third EH domains, 
was shown to disrupt the localization of AP2, clathrin and dynamin at the plasma 














Eps15, or microinjection of antibodies blocking Eps15 and Eps15L1 functionality, led to 
defects in clathrin-dependent EGFR internalization (Carbone et al., 1997). 
Over the last 10 years, it has also been demonstrated that EGFR stimulated with high doses 
of ligand is monoubiquitinated and internalized through CIE (Chen & De Camilli, 2005; 
Sigismund, et al., 2005). This pathway is preferentially used by the cell to downmodulate 
EGFR signaling, since it directs the receptor towards lysosomal degradation. In vitro, triple 
knockdown (KD) of Eps15, Eps15L1 and Epsin1 resulted in inhibition of this pathway, 
demonstrating that, together, the three proteins play an important role in targeting the 
ubiquitinated receptor to non-clathrin internalization (Sigismund, et al., 2005).  
 
2.3 Post-translational modifications of Eps15 
Eps15 is tyrosine phosphorylated by the EGFR and monoubiquitinated after stimulation 
with EGF (Fazioli, et al., 1993; van Delft et al., 1997). A mutant form of Eps15, in which 
Tyr850 is mutated into a phenylalanine, retains its protein binding properties, but is no 
longer phosphorylated by EGFR. This mutant acts as a dominant negative mutant, 
inhibiting the internalization of EGFR, but not that of the TfR (Confalonieri et al., 2000). 
This result is an indication that Eps15 and Eps15L1 might be required for ligand-induced 
internalization of receptors, as in the case of EGFR, but not for constitutive internalization, 
as in the case of TfR. The result also shows that tyrosine phosphorylation of Eps15 is 
critical for the correct function of this endocytic adaptor protein. 
Ubiquitination is a post-translational modification that is often associated with endocytosis 
and trafficking (Sigismund, et al., 2012). For instance, the EGFR is ubiquitinated by the E3 
ubiquitin ligase Cbl (de Melker et al., 2001); ubiquitination of the EGFR appears to be 
required for CIE but it is not essential for CME (Huang et al., 2007; Sigismund, et al., 
2005). Importantly, however, EGFR interaction with Cbl is required for ubiquitin-
independent endocytosis of EGFR (Huang, et al., 2007), suggesting that Cbl-mediated 
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EGFR internalization may not be related to receptor ubiquitination, but may be related to 
the recruitment of ubiquitinated endocytic adaptors, containing UIM domains, such as 
Eps15 (Polo, et al., 2002).  
Finally, it has also been demonstrated that Eps15, together with Epsin, is phosphorylated 
during mitosis. This phosphorylation inhibits the interaction of the two proteins with the 
endocytic protein AP2, and has been postulated to cause dissociation of the two proteins 
from clathrin-coated pits, resulting in the mitotic block of endocytosis (Chen et al., 1999). 
 
2.4 Other roles of Eps15 and Eps15L1 in the cell 
The high number of Eps15 and Eps15L1 interactors, the role of the two proteins in both 
CME and CIE, and their post-translational modifications at different stages of the cell 
cycle and during signaling events, all suggest that Eps15 and Eps15L1 are involved in the 
regulation of several cellular processes, possibly in a highly dynamic manner.  
For example, there are many lines of evidence indicating that the biological function of 
Eps15 and Eps15L1 is not restricted to the plasma membrane. Indeed, it has been 
demonstrated that Eps15 is able to interact with AP1, a member of the AP adaptor protein 
family involved in the formation of clathrin-coated vesicles in the trans-Golgi network 
secretory pathway (Chi, et al., 2008). Moreover, Eps15 is recruited by ubiquitinated 
coronin7 (Crn7), an F-actin regulator, and this binding promotes the recruitment of Crn7 to 
the trans-Golgi network, where it contributes to the formation of tubular carriers (Yuan et 
al., 2014). Taken together, these two observations strongly indicate a possible role for 
Eps15 in the regulation of trans-Golgi network trafficking. 
In the literature there are also reports of two isoforms of Eps15, produced by alternative 
splicing, Eps15b and Eps15s. Eps15b, which completely lacks the three EH domains at the 
N-terminus, colocalizes with the endosomal sorting protein Hrs in specific endosomal 
microdomains and mediates the sorting of the EGFR towards the degradative pathway 
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(Kostaras et al., 2013; Roxrud et al., 2008). Eps15s, which lacks 111 amino acids at its C-
terminus, including the two UIM domains, is involved in the recycling of the internalized 
EGFR back to the cell surface, in a Rab11-dependent manner (Chi et al., 2011). Several 
alternative splice forms of Eps15L1 have also been reported, however nothing is known 
about their functional specificity. 
Finally, there is evidence to suggest that Eps15 and Eps15L1 are linked to cell-cell 
adhesion and connections; Eps15 regulates internalization and trafficking of the 
components of tight junctions (Murakami et al., 2009) and internalization of connexin43, a 
base component of gap junction channels (Girao et al., 2009). Moreover both Eps15 and 
Eps15L1 are involved in the regulation of the internalization of integrin β1, through their 
binding with the endocytic adaptor Dab2 (Teckchandani et al., 2012). 
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3. Notch signaling pathway 
3.1 Importance of studying the Notch signaling pathway: Notch and human diseases 
The Notch pathway is a signal transduction pathway that is highly conserved during 
metazoan evolution. It regulates numerous aspects of development, and, in particular, it 
can influence self-renewal, proliferation, differentiation and cell fate specification (Bray, 
2006; Fortini, 2009; Kopan & Ilagan, 2009). 
Given the importance of the cellular processes that are mediated by Notch and the great 
variety of tissues in which the pathway is active, it is not surprising that alterations in 
Notch signaling regulation are the cause of several human diseases, including cancer 
(Louvi & Artavanis-Tsakonas, 2012). In fact, mutations in genes that encode for different 
Notch signaling pathway proteins, can cause developmental syndromes that affect several 
organs, such as the heart, liver, skeleton, kidney and vascular system (Gridley, 2003; Louvi 
& Artavanis-Tsakonas, 2012; Penton et al., 2012; Yavropoulou & Yovos, 2014). For 
example: 
i) the Alagille syndrome, that is caused by mutations in the Notch ligand 
Jagged1 gene and results in  pleiotropic development of organs and tissues 
(Li et al., 1997; Oda et al., 1997); 
ii) Spondylocostal Dysostosis, a disease that results in an anomalous vertebral 
development and can be caused by mutations in the Notch ligand Dll3 gene 
(Bulman et al., 2000) or by inactivating mutations in Lunatic Fringe, that 
encodes a glycosyltransferase that regulates the Notch receptors (Sparrow 
et al., 2006);  
iii) several types of cardiac congenital diseases, such as Tetralogy of Fallot, 
that can be caused by mutations in the Notch ligand Jagged1 gene (Eldadah 
et al., 2001); 
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iv) the adult disorder CADASIL (cerebral autosomal dominant arteriopathy 
with subcortical infarcts and leukoencephalopathy), a vascular disorder that 
causes transient ischemic attacks or strokes and has been linked with 
dominant mutations in the Notch receptor Notch3 gene (Joutel et al., 1996).  
Notch signaling also has a key role in inducing commitment and differentiation of the T-
cell lineage, while impairing early B-cell development (Thompson & Zuniga-Pflucker, 
2011). Consequently, Notch signaling alterations have been described in a wide variety of 
hematological tumors, including T and B cell leukemia and lymphoma, and myeloid 
leukemia (Hernandez Tejada et al., 2014). The archetypal hematological malignancy 
associated with altered Notch signaling is T-acute lymphoblastic leukemia (T-ALL), an 
aggressive neoplasm, in which the Notch1 receptor is constitutively activated either by 
chromosomal translocation (1% of the cases) or by point mutations and frame-shift 
mutations (55-60% of the cases) (Roy et al., 2007). Similarly, ≈50% of T-cell non-
Hodgkin lymphoma (T-NHL) cases and 5-15% of chronic lymphocytic leukemia (CLL) 
cases carry activating Notch1 mutations (Roy, et al., 2007). Moreover, expression of the 
Notch1 receptor and the ligands Jagged1 and Dll1 are associated with poor prognosis in 
acute myeloblastic leukemia (Hernandez Tejada, et al., 2014). 
Numerous lines of evidence also point to an involvement of altered Notch signaling in 
solid tumors. Studies in primary human breast cancers have demonstrated that increased 
expression of the Notch1 receptor and the ligand Jagged1, at the mRNA level, correlates 
with increased tumor aggressiveness and poor prognosis (Nwabo Kamdje et al., 2014). It 
has also been demonstrated that increased Notch signaling due to loss of expression of the 
Notch antagonist Numb, occurs in approximately 50% of breast carcinoma cases (Pece et 
al., 2004) and in one third of non-small-cell lung carcinomas (NSCLCs) (Westhoff et al., 
2009). Moreover, activating Notch mutations have been detected in ~10% of NSCLCs 
(Westhoff, et al., 2009). Aberrant Notch signaling has also been implicated in the 
development and progression of prostate cancer (Leong & Gao, 2008), malignant 
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melanoma (C. S. Muller, 2012), osteosarcoma (McManus et al., 2014), renal epithelial 
cancers (Sirin & Susztak, 2012), colorectal cancer (Noah & Shroyer, 2013), gliomas and 
medulloblastomas (Stockhausen et al., 2012). 
Given the extensive role of Notch signaling in cancer, several agents targeting and 
inhibiting Notch signaling are now into early clinical development. In particular, both 
agents that impair Notch proteolitic activation (such as γ-secretase inhibitors GSIs) and 
monoclonal antibodies that interfere with Notch ligand/receptor binding are now being 
tested (Takebe et al., 2014). In this context, gaining an in-depth understanding of the 
molecular mechanisms regulating Notch activation could potentially evolve in the 
identification of new successful cancer therapies. 
 
3.2 Notch signaling: an overview of Notch ligands and receptors  
Notch signaling activation requires direct contact between a signal-sending cell, expressing 
the ligand, and a signal-receiving cell, expressing the receptor. Signal transduction is short 
range, very quick and extremely responsive to modulation and downregulation (Fortini, 
2009). Both ligands and receptors are single pass type I transmembrane proteins. 
Drosophila melanogaster possesses one Notch receptor and two Notch ligands, Delta and 
Serrate. Mammalian cells, on the contrary, possess four paralogous Notch receptors 
(Notch1-4), three Delta-like ligands (Dll1, Dll3 and Dll4) and two Serrate-like ligands 
(Jagged1, Jagged2) (Figure 1.5) (Bray, 2006; Fortini, 2009; Kopan & Ilagan, 2009). 
The N-terminal portion of Notch receptors contains the Notch extracellular domain 
(NECD), which is composed of several epidermal growth factor (EGF)-like repeats (Figure 
1.5). D. melanogaster Notch and the mammalian Notch1-4 receptors differ in the number 
of EGF-like repeats that they contain (ranging from 29-36). Some of these EGF-like 
repeats undergo glycosylation as a post-translational modification and mediate interactions 
with the ligands. In particular, repeats 11-12 mediate trans interactions with ligands 
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expressed on neighboring cells, while repeats 24-29 are important for inhibitory cis 
interactions with ligands expressed in the same cell. A negative regulatory region (NRR) is 
also localized in the NECD, following the EGF repeats (Figure 1.5). This region is 
composed by three cysteine-rich repeats (LNR) and a heterodimerization domain, and has 
a key role in preventing the activation of the receptor in the absence of ligand. Three 
cleavage sites (S1, S2 and S3) are localized in an unstructured loop that protrudes from the 
NRR domain. The S1 cleavage site is the one that allows the proper maturation of the 
protein, while the S2 and S3 sites are fundamental for Notch conversion in its active form: 
i.e., the Notch Intracellular domain (NICD). The NICD is composed of a Rbp-associated 
molecule (RAM) domain, followed by seven ankyrin repeats (ANK) and a nuclear 
localization sequence (NLS) (Figure 1.5). The RAM and ANK domains are essential for 
interactions with transcriptional coactivators, such as Mastermind, in the nucleus. Finally, 
a transcriptional activation domain (TAD) and a PEST domain (Pro-Glu-Ser-Thr), which 
acts as a signal peptide for receptor degradation, are localized at the C-terminal portion of 
the protein (Figure 1.5) (Bray, 2006; Fortini, 2009; Kopan & Ilagan, 2009). 
Notch ligands are also transmembrane proteins that contain EGF-like repeats in their 
extracellular domain. Both the D. melanogaster ligands, Delta and Serrate, and the 
mammalian ligands, Delta-like (Dll1, Dll3, Dll4) and Serrate-like (Jagged1 and Jagged2), 
contain a cysteine-rich N-terminal Delta/Serrate/LAG-2 (DSL) domain, which is 
responsible for their interaction with the receptor (Figure 1.5). These ligands are also 
called canonical DSL ligands, in contrast to non-canonical ligands that lack the DSL 
domain. These non-canonical ligands are a group of structurally diverse proteins, whose 
function is still unclear, but which presumably modulate Notch receptor activity (D'Souza 





Figure 1.5 Structure of Notch ligands and receptors. 
Schematic representation of the domain structure of Drosophila melanogaster and mammalian 
Notch receptors and ligands [adapted from (Hori et al., 2013)]. 
 
 
3.3 Notch signaling: general pathway overview 
The Notch receptor is synthesized in the signal-sending cell as an approx. 300 kDa 
precursor protein; its N-terminal portion undergoes extensive O-linked and N-linked 
glycosylation and O-linked fucosylation in the Golgi compartment (Figure 1.6). In the 
trans-Golgi network, the precursor is cleaved at the S1 cleavage site by a Furin-like 
convertase. The resulting N-terminal and C-terminal fragments are then reassembled, via a 
non-covalent bond, to generate the mature heterodimeric form of the receptor, which is 
finally exported to the plasma membrane (Bray, 2006; Fortini, 2009; Kopan & Ilagan, 
2009). 
Notch receptor activation occurs at the plasma membrane following binding of the ligand 
(Figure 1.6). A second cleavage at the S2 site, mediated by the metalloprotease 
ADAM10/TACE, produces an active form of the receptor (Notch extracellular truncation, 
NEXT) that is, however, still anchored to the membrane. It is now accepted that 






























binding. This generates the force required for a conformational change in the receptor that 
exposes the S2 cleavage site, making it accessible to the ADAM10/TACE protease. A 
subsequent cleavage at the S3 site, mediated by the aspartyl protease γ-secretase, releases 
the Notch intracellular domain (NICD) soluble fragment, which then translocates into the 
nucleus (Figure 1.6). The γ-secretase-mediated cleavage can occur both at the plasma 
membrane and in the endosomal compartment. Once in the nucleus, NICD associates with 
the DNA-binding protein CSL, which in absence of NICD acts as transcriptional repressor. 
Together, NICD and CSL recruit the co-activator Mastermind and form a transcriptional 
complex that, upon the recruitment of additional co-activators, is able to activate 




Figure 1.6 Schematic overview of  activation of the Notch signaling pathway. 
The Notch receptor is produced as a 300 kDa precursor, which undergoes glycosylation, 
fucosylation and cleavage at the S1 site. The mature receptor is exported to the membrane as a 
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hetero-oligomer, where it is able to bind ligand expressed in the signal-sending cell. Ligand binding 
activates signaling via a second and third cleavage of the receptor at the S2 and S3 sites. The active 
form of the receptor (NICD) is released from the plasma membrane and translocates into the 
nucleus, where it forms complexes with the transcription activators CSL and Mastermind (Mam) 
and activates transcription of target genes. Cis-interaction between ligand and receptor result in 
signaling inhibition [adapted from (Hori, et al., 2013)]. 
 
3.4 Regulation of Notch receptors in the signal-receiving cell: glycosylation and 
proteolysis 
Notch signaling activation is tightly regulated both in the signal-sending and in the signal-
receiving cell. Both Notch receptors and ligands undergo glycosylation, phosphorylation, 
ubiquitination, proteolysis and recycling into endosomal compartments (Figure 1.6 and 
1.7). The combination of these events is critical for correct Notch signal transduction 
(Fortini, 2009; Kopan & Ilagan, 2009). 
Notch receptors are glycoproteins; many of their EGF repeats undergo both O- and N-
glycosylation. The effects of this post-translational modification are numerous and 
complex, but they all contribute to the regulation of Notch receptors during their synthesis 
and secretion (Fortini, 2009; Kopan & Ilagan, 2009; Takeuchi & Haltiwanger, 2014). Here, 
I report some examples of the effects of Notch glycosylation: 
1) The D. melanogaster O-fucosyltransferase, O-fut1 (Pofut1 in mammals), catalyzes 
the addition of O-fucose to several EGF-like repeats in the Notch extracellular 
domain (Okajima & Irvine, 2002). Loss of O-fut1 in flies, or Pofut1 in mice, causes 
strong Notch-defective phenotypes. (Okajima & Irvine, 2002; Shi & Stanley, 
2003). In vivo studies in D. melanogaster demonstrated that O-fut1 also possesses a 
chaperone activity, distinct from its fucosylation activity, which promotes Notch 
folding and its export to the plasma membrane (Okajima et al., 2008; Okajima et 
al., 2005). Similarly, in mammals, Pofut1 is required to generate a fully functional 
Notch receptor, but it is not absolutely required for Notch export to the plasma 
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membrane or folding, as it can be substituted, to a certain extent, by other enzymes 
n the cell (Stahl et al., 2008).  
2) The D. melanogaster N-acetylglucosaminyltransferase, Fringe (whose mammalian 
paralogs are Lunatic, Radical and Manic Fringe), catalyzes the addition of N-
acetylglucosamine to the O-fucose localized on the twelfth EGF-like repeat of the 
Notch receptor (Moloney et al., 2000). This modification is essential for the interaction 
of Notch with its ligand. In vivo evidence suggests that modifications by Fringe can 
modulate the Notch receptor response to Delta and Serrate ligands (Fleming et al., 
1997; Panin et al., 1997; Xu et al., 2007). The mammalian system is more complicated 
with the presence of three different Fringe enzymes, four Notch receptors and five 
ligands. Thus, the mechanism by which mammalian Fringe modulates Notch 
responsiveness to ligands is not yet fully understood, despite the fact that the question 
has been addressed by numerous studies (Rampal et al., 2005; Shimizu et al., 2001; 
Yang et al., 2005). 
3) A third enzyme involved in Notch glycosylation is the glycosyltransferase Rumi, 
identified in D. melanogaster. This enzyme catalyzes the addition of O-glucose to 
specific serine residues in the extracellular domain of the receptor (Acar et al., 2008). 
In the absence of Rumi activity, Notch is exported to the plasma membrane and is able 
to bind to the ligand, but is not cleaved at the S2 site. Hence, it has been hypothesized 
that the absence of Rumi causes the generation of misfolded receptors that cannot be 
processed by the ADAM10/TACE protease (Acar, et al., 2008). In mammals, three 
Rumi homologs exist, but only the homolog Poglut1 shows in vitro enzymatic activity 
and is able to rescue Notch phenotypes when overexpressed in mutant flies (Takeuchi 
et al., 2011).  
Notch maturation and activation is tightly regulated by a series of proteolytic cleavages 
that occur in proximity of the trans-membrane domain of the receptor (van Tetering & 
Vooijs, 2011). The first cleavage is performed by the protease Furin-like convertase that 
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cleaves the Notch precursor at the S1 cleavage site, generating two fragments that are then 
reunited by a calcium-dependent, non-covalent bond to form the mature heterodimeric 
receptor (Blaumueller et al., 1997; Logeat et al., 1998). The heterodimeric receptor is then 
exported to the plasma membrane (Figure 1.6 and 1.7).  
The second Notch cleavage occurs at the S2 site and is mediated by the metalloprotease 
ADAM10/TACE (Brou et al., 2000; Mumm et al., 2000; Parks et al., 2000). This event 
follows binding of the receptor to the ligand, and promotes the removal of the extracellular 
domain of Notch, generating a form of the receptor called NEXT, which is still anchored to 
the plasma membrane (Figure 1.6 and 1.7) (Nichols et al., 2007). The S2 cleavage site is 
situated in the NRR region of the receptor. This region has the role of preventing the 
proteolytic event in the absence of ligand. The S2 site, in fact, is exposed to the protease 
only after a conformational change of the receptor induced by ligand binding (Gordon et 
al., 2007; Sanchez-Irizarry et al., 2004). 
The NEXT fragment undergoes a third proteolytic cleavage at the S3 site that is embedded 
in the trans-membrane domain. This third cleavage, which corresponds to the last step in 
the proteolytic regulation of Notch signaling, is mediated by the γ-secretase protease 
complex and generates the soluble active Notch fragment, NICD (Figure 1.6 and 1.7) (De 
Strooper et al., 1999; Schroeter et al., 1998; Struhl & Greenwald, 1999). All these 
proteolytic steps are tightly controlled in order to ensure that only properly processed 
receptors, correctly activated by the ligand, have signaling activity (Bray, 2006; Fortini, 







3.5 Regulation of Notch receptors in the signal-receiving cell: endocytosis 
Endocytosis and membrane trafficking have also been known for a long time as essential 
regulators of Notch activity (Baron, 2012; Fortini & Bilder, 2009; Kandachar & Roegiers, 
2012). The first observation indicating an endocytic requirement for Notch activation both 
in the signal-sending and in the signal-receiving cell, comes from the analysis of the 
shibire mutant in D. melanogaster. Shibire, the Drosophila homolog of dynamin, is a 
protein required for the release of endocytic vesicles from the plasma membrane. Shibire 
mutant cells were shown to be defective both in sending and in receiving Notch signals 
(Seugnet et al., 1997). A further requirement for endocytosis and endocytic regulatory 
proteins in the signal-receiving cell was demonstrated in the Drosophila sensory organ 
precursor (SOP) cell. This cell generates two daughter cells, the pIIa and pIIb cells 
(Hartenstein & Posakony, 1989); pIIa cells require Notch activation for fate specification, 
while overexpression of Notch in the pIIb cells causes a switch into a pIIa cell (Hartenstein 
& Posakony, 1990). 
During SOP cell mitosis, the endocytic adaptor protein Numb is asymmetrically segregated 
into the pIIb cell; there it binds Notch and interacts with other endocytic adaptor proteins, 
and acts as a negative regulator of the Notch receptor (Berdnik et al., 2002; Tang et al., 
2005). The mechanism through which Numb negatively regulates Notch is still unknown, 
however, two hypotheses have been proposed. The first hypothesis proposes that Numb 
inhibits Notch by promoting its endocytosis, therefore, its removal from the plasma 
membrane and subsequent degradation (McGill & McGlade, 2003). The second hypothesis 
instead proposes that Numb alters Notch intracellular trafficking, and prevents newly 
synthesized receptor to reach specific plasma membrane micro-domains (Couturier et al., 
2012). Moreover, Numb might also modulate Notch activity in an indirect fashion, by 
sequestering the positive Notch regulator Sanpodo (Hutterer & Knoblich, 2005; O'Connor-
Giles & Skeath, 2003). AP1, a complex of endocytic adaptor proteins that localizes to the 
trans-Golgi network and recycling endosomes, is also able to suppress Notch signaling 
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activation in the pIIb cells, probably by impairing accumulation of Notch or Sanpodo at the 
apical membrane of the cell (Benhra et al., 2011).  
Ubiquitination of Notch also plays an important role in the regulation of Notch trafficking 
(Fortini, 2009). A number of E3 ubiquitin ligases, such as Nedd4 and Cbl, have been 
shown to target Notch for degradation (Gupta-Rossi et al., 2004; Jehn et al., 2002; Sakata 
et al., 2004; M. B. Wilkin et al., 2004), while the E3 ligase Deltex acts as a positive 
regulator of Notch influencing its endosomal partitioning (M. Wilkin et al., 2008). 
Of note, non-activated Notch is also internalized, subjected to endosomal trafficking, and 
either recycled or degraded. This constitutive endocytosis of Notch is exploited by the cell 




Figure 1.7 Schematic overview of the complex regulation of Notch signaling pathway. 
The figure shows a schematic representation of a signal-sending cell (blue) that expresses the 
Notch ligands Delta and Jagged, and a signal-receiving cell (green) that expresses the receptor 
Notch. The main points of Notch receptor and ligand regulation are marked by numbers. (1) 
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Receptor maturation: the Notch receptor, before export to the plasma membrane, undergoes several 
steps of maturation, including glycosylation of the EGF repeats in the extracellular domain and a 
proteolytic cleavage at the S1 site, followed by reassembly of the two protein fragments. (2) 
Endosomal sorting: numerous endocytic proteins regulate the export of the receptor to the plasma 
membrane or its entry into the endosomal compartment. From here the receptor can be directed 
towards the degradative pathway, resulting in downregulation of the signal, or towards a recycling 
pathway that recycles receptor back to the plasma membrane. (3) Ligand maturation: the two 
ubiquitin E3 ligases Neuralized (Neur) and Mindbomb (Mib) and the endocytic protein Epsin 
promote the internalization of inactive DSL ligands, directing them towards a recycling pathway 
during which they are activated. (4) Regulated proteolysis: ligand-dependent Notch activation is 
controlled by a series of tightly controlled proteolytic cleavages that generate the fragment NEXT 
and later the soluble NICD fragment that translocates into the nucleus. (5) Transcriptional switch 
and target genes expression: in the nucleus NICD binds the transcriptional activators CSL and 
Mastermind (Mam); together they form a ternary complex capable of activating Notch target genes 
transcription. (6) Signal downregulation: once generated, the NICD fragment, can only be 
downregulated by degradation, which mediates the disassembly of the NICD/CSL/Mam complex 
[adapted from (Ilagan & Kopan, 2007)]. 
 
3.6 Endocytic regulation of Notch ligands in the signal-sending cell: D. melanogaster 
The regulation of Notch ligands in the signal-sending cell is still a poorly defined process 
that remains under investigation today. It is known that endocytosis and endosomal 
trafficking play a crucial role in the activation and signaling ability of Notch ligands 
(D'Souza, et al., 2008; Musse et al., 2012). The majority of data regarding this aspect of 
Notch regulation has been obtained in D. melanogaster and only subsequently confirmed 
in mammalian models. As already reported in the previous section, the first data 
demonstrating a critical role for endocytosis in the regulation of Notch signaling, came 
from the analysis of the dynamin shibire mutant in D. melanogaster (Seugnet, et al., 1997). 
The novel observation, however, was that not only this requirement was true for the signal-
receiving cell, but also for the signal-sending. Dynamin-dependent Delta endocytosis in the 
signal-sending cell was in fact necessary to produce an active NICD in the signal-receiving 
cell (Parks, et al., 2000). It was subsequently demonstrated that endocytosis of Notch 
ligands is promoted by monoubiquitination of their cytoplasmatic tails. The enzymes 
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responsible for this monoubiqitination are the ubiquitin E3 ligases Neuralized (Neur) and 
Mindbomb (Mib) (Itoh et al., 2003; Lai et al., 2001; Lai et al., 2005; Wang & Struhl, 2005). 
Moreover, the endocytic adaptor protein liquid facet (homolog of mammalian Epsin) was 
also found to be strictly required for ubiquitin-dependent ligand internalization and Notch 
signaling (Wang & Struhl, 2004; Wang & Struhl, 2005). 
As previously described, Epsin is an endocytic adaptor that participates in CME and CIE 
together with Eps15 and Eps15L1 (Chen, et al., 1998; Sigismund, et al., 2005). Likewise 
Eps15 and Eps15L1, Epsin possesses two UIMs that mediate interactions with 
ubiquitinated proteins, and is itself subject to ubiquitination (Polo, et al., 2002). Moreover, 
it has been shown that the presence of an Epsin N-Terminal Homology (ENTH) domain 
localized at the N-terminal of Epsin, can induce membrane curvature (Chen, et al., 1998; 
Ford et al., 2002). Epsin also possesses two clathrin-binding domains (Drake et al., 2000), 
a DPW (Asp-Pro-Trp)-rich region that binds the endocytic adaptor AP2, and three NPF 
motifs that bind endocytic proteins containing an EH domain, such as Eps15 and Eps15L1 
(Rosenthal et al., 1999). A recent structure-function analysis performed in D. melanogaster, 
demonstrated that one of the two UIM domains and the ENTH domain of Epsin are 
essential for Notch signaling activation (Xie et al., 2012). However, the clathrin-binding 
domain seems to be dispensable, indicating that in the D. melanogaster female germline 
Notch ligand is endocytosed via a CIE route (Xie, et al., 2012). However, CME 
involvement in Notch ligand activation in D. melanogaster remains at present controversial, 
with different observations suggesting that clathrin requirement in Notch ligand 
endocytosis might be context dependent (Eun et al., 2008; Hagedorn et al., 2006; Windler 
& Bilder, 2010).  
To explain the requirement for ligand endocytosis in Notch signaling, two non-mutually 
exclusive models have been proposed. The first model, called the ‘recycling model’, 
proposes that the newly synthesized ligand exported to the plasma membrane is not 
competent to signal; the ligand needs to be internalized and recycled back to the plasma 
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membrane in order to be active. During this process, it has been proposed that the ligand 
undergoes an unknown post-translational modification or a conformational change 
(D'Souza, et al., 2008; Kandachar & Roegiers, 2012; Le Borgne, 2006; Musse, et al., 2012). 
The major supporting data for this model comes from studies in the D. melanogaster SOP 
cell. In this cell, it has been demonstrated that the GTPase Rab11 that is active in recycling 
endosomes, and Sec15, a component of the exocist complex, are necessary for Delta 
recycling and Notch activation (Emery et al., 2005; Jafar-Nejad et al., 2005). Moreover, in 
the same cell it has been shown that the Eps15 homology domain containing protein-
binding protein 1 (dEHBP1) interacts with Rab11 and Sec15 to assist in the exocytosis and 
recycling of Delta (Giagtzoglou et al., 2012).  
Another variant of the ‘recycling model’ proposes that recycling is needed to relocate the 
ligand to a specific lipid-enriched microdomain of the plasma membrane, which might 
favor clustering of the ligand. This model is supported by two different studies. The first 
study proposes that the phosphoinositide-binding motif of Neuralized mediates endocytosis 
of Delta after its ubiquitination, suggesting that Delta might need to be located in a specific 
lipid microdomain environment to be activated (Skwarek et al., 2007). The second study 
suggests that changes in the glycosphingolipid composition of the membrane can rescue 
the Delta and Serrate signaling and trafficking defects obtained after Mindbomb inhibition 
(Hamel et al., 2010). 
The second model, called the ‘pulling forces model’ proposes that, after binding to Notch, 
ligand, endocytosis in the signal-sending cell is required to exert a mechanical force on the 
receptor in the signal-receiving cell. This force would be able to induce a conformational 
change in the receptor that allows unmasking of the S2 metalloprotease cleavage site, and 
subsequent activation of the pathway (D'Souza, et al., 2008; Kandachar & Roegiers, 2012; 
Le Borgne, 2006; Musse, et al., 2012). This second model is mainly supported by the fact 
that, although in SOP cells, Rab11 and Sec15 are required to activate Notch signaling, 
neither Rab11 nor Rab5 are necessary for Notch ligand to activate Notch in the D. 
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melanogaster germline or in the developing eye, excluding a role for recycling requirement 
in this context (Banks et al., 2011; Windler & Bilder, 2010). Major support for this model 
also comes from studies performed in mammalian cells that will be discussed in the next 
section. 
 
3.7 Endocytic regulation of Notch ligands in the signal-sending cell: mammalians 
The role of the mammalian orthologs of the D. melanogaster genes, Neuralized, 
Mindbomb and Liquid facet, has also been explored. Genetic studies in knockout (KO) 
mice have helped to clarify the role of these proteins in vivo. In particular, it has been 
shown that Neuralized1 and Neuralized2 deletion in mice, contrary to expectations based 
on D. melanogaster data, does not lead to a lethality phenotype, since the mice are healthy 
and display few Notch related phenotypes (Koo et al., 2007; Ruan et al., 2001; Vollrath et 
al., 2001). The same is true for the Mindbomb2 KO mice (Koo, et al., 2007). In contrast, 
Mindbomb1 KO mice are embryonic lethal and conditional inactivation of Mindbomb1 in 
different tissues, such as the endothelium, skin epithelium, cerebellum and apical 
ectodermal ridge, revealed phenotypes characteristic of Notch loss-of-function mutants 
(i.e., Dll4, Jag1 and Jag2 mutant mice) (Koo et al., 2005; Koo, et al., 2007). These data 
suggest that in mammalians Mindbomb1 is the key ubiquitin E3 ligase involved in the 
regulation of Notch ligands. This role of Mindbomb1 was confirmed by reciprocal bone 
marrow transplantation experiments that demonstrated that Mindbomb1 in the thymic and 
splenic microenvironments is essential for Notch dependent T and Marginal Zone B cell 
development, respectively (Song et al., 2008). Moreover, silencing of Mindbomb1 in the 
OP9-Dll1 cell line, a stromal murine cell line that overexpresses the ligand Dll1, abolished 
T cell development in vitro and inhibited Dll1 endocytosis (Song, et al., 2008). 
A double KO mouse for the two murine Epsins (Epsin1 and Epsin2) has also been 
generated (Chen et al., 2009). While the single KO mice for these two proteins are viable 
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and show no phenotypic defects, the Epn1/Epn2  double KO (DKO) mouse is embryonic 
lethal and displays phenotypes that recapitulate several defects caused by Notch loss-of-
function (Chen, et al., 2009). Moreover, a recent in vitro study characterizing the endocytic 
and cellular components necessary for Dll1 ligand activation, confirmed a fundamental 
role of Epsin1 and Epsin2, together with clathrin (but not AP2 and caveolin1) in the 
regulation of Dll1 activity and its endocytosis (Meloty-Kapella et al., 2012). Using a cell-
bead optical tweezer system, the authors also demonstrated that the primary role for Notch 
ligand endocytosis is not recycling, but rather to generate mechanical forces needed for the 
conformational change and subsequent activation of the receptor, thus supporting the 
“pulling force” model (Meloty-Kapella, et al., 2012; Shergill et al., 2012).  
Nevertheless, the requirement for Notch ligand recycling in mammalian cells has not been 
disproved and seems to be at least context dependent, especially in polarized cells. There 
are in fact data that report that Neuralized is able to promote Dll1 recycling from the 
basolateral to the apical membrane of polarized cells (Benhra et al., 2010). Biochemical 
proof of the requirement of ligand recycling in mammalian cells has been obtained using a 
mutant Dll1 protein lacking the 17 lysine residues in its intracellular domain (Heuss et al., 
2008). This mutant protein is not ubiquitinated and undergoes endocytosis, but is not able 
to be recycled to the plasma membrane or to bind the Notch1 receptor efficiently. 
Moreover, a chimeric protein obtained fusing the extracellular domain of the ligand Dll1 
and the intracellular domain of the ligand Dll3, which contains no lysine residues, is 
internalized, recycled to the plasma membrane and is able to interact with Notch1, but is 
not able to promote signal transduction (Heuss, et al., 2008). A lysine residue (K613) has 
also been identified in the cytoplasmic tail of Dll1 as a critical residue for Notch signaling 
activation; mutation of Dll1-K613 to R generated a ligand that was not able to physically 
interact with Notch1 receptor or to activate Notch signaling, although its endocytic 
recycling and stability were unaltered (Zhang et al., 2011). However, localization of the 
mutant to lipid raft microdomains was enhanced (Zhang, et al., 2011). It has also been 
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demonstrated that mammalian Dll1 contains a glycosphingolipid binding domain and is 
associated with specific lipidic microdomains of the plasma membrane, suggesting that 
ligand trafficking and activity can be modulated by their localization in a lipid environment 
(Heuss et al., 2013). Further studies aiming to elucidate the role of internalization and 
recycling in Notch ligand regulation have been performed on the Notch ligand Dll4. In 
particular, it has been shown that Dll4 is also able to undergo internalization and recycling, 
and to interact with Mindbomb1 (Shah et al., 2012). However, Dll4 showed a different 
localization in the plasma membrane domains compared to Dll1, with Dll4 being excluded 
from lipid rafts. Taken together, these results indicate that in mammalian cells the two 
Notch ligand activation models, “recycling/relocalization” and “pulling forces”, are likely 
to be not mutually exclusive, and, at least in some contexts, the two events could take place 
consecutively. 
 
3.8 Regulation of Notch ligands in the signal-sending cell: glycosylation and 
proteolysis 
Notch ligands, as Notch receptors, also appear to be regulated by glycosylation and 
proteolysis. At present, the role of glycosylation in Notch ligand regulation is mainly 
unexplored; both D. melanogaster Notch ligands, Delta and Serrate, as well as their 
mammalian counterparts, Dll1 and Jagged1, contain several consensus sequences for O-
fucosylation. It has been demonstrated that both D. melanogaster and mammalian ligands 
are substrates of O-fut1/Pofut1 and that the added O-fucose can be elongated by Fringe 
(Panin et al., 2002). However, a very recent paper argues against a substantial regulation of 
Notch ligands activity by this modification, since a Dll1 protein with mutated O-
fucosylation sites was able to reach the cell surface; likewise wild type Dll1 expressed in 
cells lacking Pofut1, was also able to reach the cell surface and to activate Notch (J. Muller 
et al., 2014). 
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Notch ligands can undergo two proteolytic cleavages in the proximity of their 
transmembrane domain. These two cleavages are mediated by ADAM proteases and by γ-
secretase. Although it is clear that ligand proteolysis affects Notch signaling by decreasing 
ligand levels and availability at the plasma membrane, there is still controversy over 
whether the products of the proteolytic events have an intrinsic activity (D'Souza, et al., 
2008). Mammalian DSL ligands can be cleaved by numerous ADAMs: ADAM9, 
ADAM10, ADAM12, ADAM17; however, only the ADAM10 and ADAM17 homologues 
are responsible for cleavage of the D. melanogaster ligands. These proteases cleave Notch 
ligands at multiple sites and the product of this cleavage is a portion of the ligand still 
anchored to the plasma membrane (TMICD) (Zolkiewska, 2008). In mammalian cells, the 
TMICD can undergo a second cleavage by γ-secretase (Ikeuchi & Sisodia, 2003; Six et al., 
2003). Moreover, there is evidence that the product of this second cleavage (ICD) 
translocates into the nucleus and activates the transcription of various reporter genes 
(Hiratochi et al., 2007; Kolev et al., 2005; LaVoie & Selkoe, 2003). Together, these 
observations have provided the basis for the speculation that the ICD could mediate 
reverse signaling in the signal-sending cell. However, two recent studies in mice 
overexpressing various versions of Dll1-ICD and in endothelial cells overexpressing 
Jagged1-ICD, Dll-ICD and Dll4-ICD, indicate that this proposed bi-directional ligand 
signaling might not have much relevance in physiological contexts (Liebler et al., 2012; 
Redeker et al., 2013). 
 
3.9 Transcriptional feedback regulation of Notch receptors and ligands: lateral 
inhibition 
A last aspect that needs to be discussed in the context of Notch regulation, both in the 
signal-sending and the signal-receiving cell, is the concept of “lateral inhibition”. This 
concept refers to a transcriptional feedback mechanism that explains how Notch signaling 
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can lead to different cell fates in two initially identical progenitor cells, as in the case of 
neuroblast differentiation in the neurogenic region of the D. melanogaster embryo (Bray, 
2006; Fortini, 2009). In this example, two initially equivalent interacting cells express 
comparable levels of Notch receptor and DSL ligands, and are at the same time both a 
signal-sending and signal-receiving cell. Notch ligands, in addition to being able to activate 
Notch receptors in trans on the neighboring cell, can negatively modulate Notch receptors 
in the same cell in a cis fashion, both at the plasma membrane and during the secretory 
pathway. When a stochastic difference in ligand and receptor levels arises in the two 
initially identical cells, the cell with a stronger Notch signaling will overcome the cis-
inhibition of Notch by the ligand, resulting in upregulation of receptor expression. In 
contrast, in the cell with the weaker Notch signaling, receptor activity is downmodulated 
and ligand expression increases. In this way, a stable feedback amplification loop is 
established and the two cells adopt a signal-receiving and a signal-sending cell fate, 
respectively (Bray, 2006; Fortini, 2009). 
This mechanism has also been investigated in mammalian cells through a quantitative 
time-lapse microscopy approach that allowed the authors to determine that while the Notch 
response to Delta in trans is graded, its response to Delta in cis is sharp and occurs at a 
fixed threshold (Sprinzak et al., 2010). These results contribute to our understanding of 
“lateral inhibition” in a multicellular organism, explaining how this mechanism can 
amplify small initial differences between neighboring cells. 
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4. Eps15/Eps15L1 and Notch signaling regulation 
4.1 Eps15, Eps15L1 and Eps15/Eps15L1 knockout mice  
Genetically engineered mice are an effective model system to study the in vivo function of 
a protein. KO mouse models, in which a specific protein has been inactivated (or knocked 
out) by disrupting its gene of origin, are particularly useful in studying the biological roles 
of proteins. The loss of the protein of interest can cause changes in the mouse phenotype at 
different levels: it can cause lethality, alteration of developmental processes, behavioral 
problems and other biochemical or physiological alterations.  
To obtain insights into the physiological function of Eps15 and Eps15L1 in mammals, KO 
mice for Eps15, Eps15L1 and Eps15/Eps15L1 combined (i.e., the double KO, DKO) were 
generated in our laboratory, prior to the beginning of this thesis project. The Eps15 KO 
mice are viable, healthy and fertile and do not show any obvious phenotype beside a defect 
in B cell lymphopoiesis (Pozzi et al., 2012). In contrast, the Eps15L1 KO mice are 
perinatal lethal due to a defect in the nervous system that impairs feeding (Alberici et al., 
manuscript in preparation). Eps15/Eps15L1 DKO mice, however, are embryonic lethal. 
The mice die at midgestation, around 10.5 days after fertilization. Morphological analysis 
of 9.5-day-old Eps15/Eps15L1 DKO embryos revealed numerous developmental defects, 
such as cardiovascular defects and absence of limb buds. Moreover, more severely affected 
embryos showed an open neural tube, absence of turning and lack of caudal somites 




Figure 1.8 Morphological analysis of Eps15/Eps15L1 DKO embryos at 9.5 days post-
fertilization and comparison with Notch signaling loss-of-function KO embryos. 
A. Photographs displaying the phenotype of Eps15-KO and Eps15/Eps15L1-DKO littermates at 9.5 
days post-fertilization. The Eps15-KO embryo displays a wild type phenotype. Arrows indicate the 
midbrain/hindbrain boundary (Bd), the limb bud (Lb) and the heart (Ht). The asterisk in the middle 
picture indicates the absence of limb bud. All the photographs are at the same magnification. 
B. Photographs displaying the midgestation embryo phenotype of the Tie2Cre/Notch1-KO 
[adapted from (Limbourg et al., 2005)], Dll4-KO [adapted from (Duarte et al., 2004)], Numb-KO 
[adapted from (Zilian et al., 2001)], Epsin1/Epsin2 KO [adapted from (Chen, et al., 2009)] and 
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4.2 Eps15 and Eps15L1: hypothesis on Notch signaling regulation  
Most of the alterations identified in the Eps15/Eps15L1 DKO mice phenocopy various 
characteristics of Notch signaling loss-of-function mice, such as the Notch1 KO 
(Limbourg, et al., 2005; Swiatek et al., 1994), Notch1/Notch4 DKO (Krebs et al., 2000), 
Dll1 KO (Hrabe de Angelis et al., 1997), Dll4 KO (Duarte, et al., 2004), Jagged1 KO (Xue 
et al., 1999), Numb KO (Zilian, et al., 2001), Epsin1/Epsin2 DKO (Chen, et al., 2009) and 
Mib1 KO (Koo, et al., 2005) (Table 1 and Figure 1.8B). 
To understand if Notch signaling, together with other signaling pathways, was indeed 
deregulated in the absence of Eps15 and Eps15L1, a microarray analysis was performed on 
9.5-day-old embryos, comparing 3 sets of Eps15 KO, Eps15L1 KO and Eps15/Eps15L1 
DKO littermates. The majority of the genes found altered in the DKO mice recapitulated 
the morphological changes in the embryos; in particular, genes involved in cardiac and 
neural development, in hematopoiesis and in metabolism were deregulated (Table 2). 
Numerous genes were also found altered in the signaling category; however, no single 
pathway was prominently affected. Major signaling pathways, such as Smad, β-catenin and 
Hedgehog, were not deregulated. However, the Notch target genes Hes1, Hes5 and NRAP 
were downregulated in DKO embryos. To confirm these findings, a QPCR analysis of 9.5-
day-old embryos was performed, using Epsin1/Epsin2 DKO embryos as a control for 
alterations in Notch signaling target genes (Figure 1.9). Notch target genes Hes1, Hes5 and 
NRAP were confirmed as downregulated in the Eps15/Eps15L1 DKO, to the same extent 
as in Epsin1/Epsin2 DKO mice (Figure 1.9A).  In contrast, the β-catenin target genes 
Axin2 and Lef1, the TGF-β signaling proteins Smad6 and Smad7, and the Hedgehog target 
gene Gli1, were shown to be unaltered in Eps15/Eps15L1 DKO mice, confirming the 
microarray data (Figure 1.9B-D).  
Taken together, these observations suggest that loss of both Eps15 and Eps15L1 correlates 
with a Notch loss-of-function phenotype. Considering the fact that these proteins are also 
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known to interact with two major Notch signaling regulators, Numb and Epsin (Chen, et 
al., 1998; Salcini, et al., 1997), we hypothesized that Eps15 and Eps15L1 could also act as 
Notch regulators, either in the signal-sending or in the signal-receiving cell. 
 
 
Table 1. Summary of the main phenotypic effects displayed by embryos knocked out for the 

















































Notch1/Notch4 Receptor < 11.5 dpc YES YES YES (Krebs, et al., 
2000) 
Dll1 Ligand < 11.5 dpc YES / YES (Hrabe de 
Angelis, et al., 
1997) 
Dll4 Ligand < 11.5 dpc YES YES / (Duarte, et al., 
2004) 
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Table 2. Summary of the major gene categories found altered in the microarray analysis performed 





Figure 1.9 Downregulation of Notch target genes in Eps15/Eps15L1 DKO embryos at 9.5 
days post-fertilization. 
A. Bar graph depicting the relative expression levels of Hes1 (white bars), Hes5 (grey bars) and 
NRAP (black bars) Notch target genes in wild-type (WT), Eps15/Eps15L1-DKO (DKO), Eps15L1-
KO (15L1), Eps15-KO (15) and Epsin1/Epsin2-DKO (E1/2) 9.5-day-old embryos, as determined 
by QPCR.  
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B. Bar graph depicting the relative expression levels of axin2 (white bars) and lef1 (black bars) 
Wnt/β-catenin target genes in wild-type (WT), Eps15/Eps15L1-DKO (DKO), Eps15L1-KO (L1KO) 
and Eps15-KO (15KO) 9.5-day-old embryos as determined by QPCR.  
C. Bar graph depicting the relative expression levels of smad7 (white bars) and smad6 (black bars) 
in wild-type (WT), Eps15/Eps15L1-DKO (DKO), Eps15L1-KO (L1KO) and Eps15-KO (15KO) 
9.5-day-old embryos as determined by QPCR.  
D. Bar graph depicting the relative expression levels of the Hedgehog target gene Gli (black bars) 
in wild-type (WT), Eps15/Eps15L1-DKO (DKO), Eps15L1-KO (L1KO) and Eps15-KO (15KO) 
9.5-day-old embryos, as determined by QPCR.  
A-D. All values were normalized on GAPDH and on the relative expression levels of WT embryos. 
At least 3 independent embryos were analyzed for each gene, except for Epsin1/Epsin2-DKO (n=1). 






A number of observations point to a role for Eps15 and Eps15L1 in the endocytic 
regulation of Notch signaling: 
i) Morphological analysis of the Eps15/Eps15L1 DKO mice suggests that ablation of the 
two proteins causes a putative Notch loss-of-function phenotype, since Eps15/Eps15L1 
embryos closely resemble those of KO mice for different components of the Notch 
pathway; moreover the Notch target genes Hes1, Hes5 and NRAP are downregulated in 
Eps15/Eps15L1 DKO embryos. 
ii) Eps15 and Eps15L1 physically interact with Numb and Epsin, key regulators of Notch 
receptor and ligand activity, respectively. 
iii) Eps15 and Eps15L1 act in complex with Epsin1 to modulate EGFR endocytosis. 
iv) Both Eps15 and Eps15L1 possess UIM domains, one of the two essential domains 
needed for Epsin-dependent activation of Notch ligands. 
Despite these observations, there is no direct evidence demonstrating the involvement of 
Eps15 and Eps15L1 in the endocytic regulation of Notch. 
Thus, the overall aim of this project is to characterize the involvement of Eps15 and 
Eps15L1 in Notch signaling regulation. Specifically, we will first assess whether Eps15 
and Eps15L1 are able to directly affect Notch signaling (Results Chapter 1-4). To achieve 
this, it is necessary to set-up a suitable model system that allows measurement of trans 
activation of Notch (Results chapter 1-2). Subsequently, we will investigate whether Eps15 
and Eps15L1 modulate Notch signaling by regulating the activity of the receptor in the 
signal-receiving cell or the activity of the ligand in the signal-sending cell (Result Chapters 
3 and 4). Finally, to define the molecular mechanisms underlying the putative regulation of 
Notch signaling by Eps15 and Eps15L1, we will assess if this occurs through modulation 




Chapter 2  
MATERIALS AND METHODS 
 
1. Solutions and Buffers 
1.1 Phosphate-buffered saline (PBS) 
NaCl 137 mM 
KCl 2.7 mM 
Na2HPO4 10 mM 
KH2PO4 2 mM 
8 g of NaCl, 0.2 g of KCl, 1.44 g of Na2HPO4, and 0.24 g of KH2PO4 were dissolved in 
800 ml of distilled water. The pH was adjusted to 7.4 with HCl and the volume was 
brought to 1 litre with distilled H2O. 
 
1.2 Tris-HCl (1 M) 
121.1 g of Tris base were dissolved in 800 ml distilled H2O. The pH was adjusted to 7.4, 
7.6 or 8.0 with HCl, and distilled H2O was added to bring the volume up to 1 litre. 
 
1.3 Tris-buffered saline (TBS) 
NaCl 137 mM 
KCl 2.7 mM 
Tris HCl pH 7.4 25 mM 
8 g of NaCl, 0.2 g of KCl, and 3 g of Tris base were dissolved in 800 ml of distilled H2O. 
The pH was adjusted to 7.4 with HCl and distilled H2O was added to bring the volume up 
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to 1 litre. 
 
1.4 10X SDS-PAGE running buffer 
Glycine 192 mM 
Tris HCl, pH 8.3 250 mM 
SDS 1% 
 
1.5 10X Western transfer buffer 
Glycine 192 mM 
Tris HCl, pH 8.3 250 mM 
For 1X western transfer buffer, the 10X stock was diluted 1:10 with ddH2O and 20% v/v 
ethanol. 
 
1.6 JS lysis buffer 
HEPES, pH 7.4 50 mM 
NaCl 150 mM 
Glycerol 10% 
Triton X-100 1% 
MgCl2 1.5 mM 
EGTA 5 mM 
200X Protease inhibitor cocktail (Calbiochem, 539131), sodium pyrophosphate pH 7.5 
20mM, sodium fluoride 250 mM, PMSF 2 mM, and sodium orthovanadate 10 mM, final 





2.1 DNA constructs 
The pBabe plasmid expressing human Notch1 HA-tagged at the N-terminal and FLAG-
tagged at the C-terminal (pBABE-HAN1FLAG) was a gift from Maddalena Donzelli (IEO, 
Milano). The pCS2 plasmid expressing murine Notch1 Intracellular domain (pCS2-ICV-
6MT) was generated by Schroeter and collegues (Schroeter, et al., 1998). The firefly 
luciferase Notch reporter construct pGa981-6 was generated by Kurooka and collegues 
(Kurooka et al., 1998). The renilla luciferase pRL-TK vector has been purchased from 
Promega. 
 
2.2 TaqMAN assays for RT qPCR 
The TaqMAN assays for RT qPCR (Applied Biosystems) were: 
o Notch1: mm00435245_m1 
o Notch2: mm00803077_m1 
o Notch3: mm00435270_m1 
o Notch4: mm00440525_m1 
o Dll1: mm00432841_m1 
o Dll3: mm00432854_m1 
o Dll4: mm00444619_m1 
o Jagged1: mm00496902_m1 
o Jagged2: mm00439935_m1 
o Numb: mm00477927_m1 





The following antibodies were used: 
Immunofluorescence: armenian hamster monoclonal anti-Dll1 HMD1-3 Biolegend 
(1:500).  
Western blot: mouse monoclonal anti Eps15 3T (Poupon et al., 2002) (1:3), rabbit 
polyclonal anti Eps15L1 home made raised against full-length mouse Eps15L1 fused to 
GST (1:2000), mouse monoclonal anti Epsin1 ZZ3 home made raised against aminoacids 
249-401 of human Epsin1 (1:100) (a gift from Simona Polo), rabbit polyclonal anti Epsin2 
(a gift from Pietro de Camilli) (1:500), mouse monoclonal anti Vinculin Sigma (1:10000), 
mouse monoclonal anti HA 16B12 Covance (1:1000), mouse monoclonal anti FLAG 
Sigma (1:10000), rabbit polyclonal anti Mib1 M5948 Sigma (1:1000), mouse monoclonal 
anti AP2 610501 BD Bioscience (1:1000), mouse monoclonal anti Dynamin1/2 Hudy-1 
EDM Millipore (1:2000), rabbit monoclonal anti Clathrin heavy chain D3C6 Cell signaling 
(1:1000), mouse monoclonal anti-NUMB Ab21 (Colaluca et al., 2008) raised against 
amino acids 537–551 of human NUMB (1:250), rabbit monoclonal anti Caveolin-1 D46G3 
Cell Signaling (1:1000), mouse monoclonal anti β-Tubulin AA2 Sigma (1:10000), rabbit 
monoclonal anti EGFR 4267 Cell Signaling (1:1000), rabbit monoclonal anti Dll1 2588 
Cell Signaling (1:2000). 
Cytofluorimetry: armenian hamster monoclonal anti Dll1 HMD1-3 Alexa Fluor 647 









2.4 RNAi Oligonucleotides 













(Invitrogen) 10 nM 
Negative 
Control_CTR 2 AGCGAACACGTCACCGAC 
Stealth 
(Invitrogen) 10 nM 
Negative 
Control_CTR 3 AGACGAACAAGUCACCGACCCCC 
IBONI  
(Riboxx) 5 nM 
Numb_01 UUCUUCAUCUGUCUGCCACCCCC IBONI  (Riboxx) 5 nM 
Numb_02 UAAACGUCUUUCUUUCUCCCCC IBONI  (Riboxx) 5 nM 
Numb-like_02 AGGUAACAGAGUCUUCAUCCCCC IBONI  (Riboxx) 5 nM 
Numb-like_03 ACUCUGCCGUAACUUGUUCCCCC IBONI  (Riboxx) 5 nM 
dynamin 2 UGAACUGCAGGAUCAUGUCCCCC IBONI  (Riboxx) 5 nM 
Eps15_51 CCCUUAAACUGAAUGAUCCAUUUCA Stealth (Invitrogen) 10 nM 
Eps15_52 CCCAGGCAAUGAUAGUCCCAAAGAA Stealth (Invitrogen) 10 nM 
Eps15_53 AGAUGAAGUUCAAAGGGAGAGUAUU Stealth (Invitrogen) 10 nM 
Eps15L1_54 GCAAAGUUUGAUGGCAUCUUUGAAA Stealth (Invitrogen) 10 nM 
Eps15L1_55 GGAAAUCCGUUAUACGAGUCUUAUU Stealth (Invitrogen) 10 nM 
Eps15L1_56 GGCAUCAGGAGAGUUCACUGGUGUU Stealth (Invitrogen) 10 nM 
Mindbomb1 GGUGCUAAGCUAGACAUUCAGGAUA Stealth (Invitrogen) 10 nM 




(Riboxx) 20 nM 
Epsin1_48 GACUGGCUCUGAGGCUGUAUCACAA Stealth (Invitrogen) 10 nM 
Epsin1_49 GCAAGAACUGGAGGCACGUCUACAA Stealth (Invitrogen) 10 nM 
Epsin1_50 AGUUUGAGCCGAGAGGAGCACGAUA Stealth (Invitrogen) 10 nM 
Epsin2_66 GAGCUCUUCAGUAAUUUCAACGGUA Stealth (Invitrogen) 10 nM 
Epsin2_67 CGGAGAUCAUGAGCAUGGUUUGGAA Stealth (Invitrogen) 10 nM 
Epsin2_68 CCCAACCUUUCUACCAGCUACUCAG Stealth (Invitrogen) 10 nM 
 
 60 
3. Cell lines and cell culture conditions 
3.1 Cell lines and growth conditions 
The stromal murine cell line OP9 (Kodama et al., 1994) was obtained by ATCC. The 
stromal murine cell line OP9 constitutively overexpressing the Notch ligand Dll1 (OP9-
Dll1) was generated in the Zunica-Pflucker laboratory (Schmitt & Zuniga-Pflucker, 2002). 
The OP9-Dll4, OP9-Jagged1 and OP9-Jagged2 cell lines (Van de Walle et al., 2011) were 
a gift from Tom Taghon (Ghent University Hospital). All the OP9 and OP9-derived cell 
lines were maintained in Minimum Essential Medium with GlutaMAXTM (MEM 
GlutaMAXTM, Gibco) supplemented with 20% fetal bovine serum (FBS, Hyclone), 1% 
Non Essential Aminoacids (NEAA) 100x (EuroClone) and 1% Sodium Pyruvate 100 mM 
(EuroClone). 
The C2C12 cell line, obtained by ATCC, is a subclone of the murin myoblast cell line 
established by Yaffe and Saxel (Yaffe & Saxel, 1977), and it was maintained in Dulbecco's 
Modified Eagle Medium with GlutaMAXTM (DMEM GlutaMAXTM, Gibco) supplemented 
with 10% FBS (Hyclone). 
All cells were kept cultured in 10 cm cell culture dishes under sterile conditions in a 
humidified incubator at 37 °C and 5% CO2. Culturing media was changed every 2/3 days; 
cells were harvested at 80-90% confluency and replated at a ratio of 1:3-1:6 for OP9 and 
OP9-derived cell lines, and 1:5-1:10 for C2C12 and C2C12 derived cell lines.  
 
3.2 Harvesting of cells and long-term storage 
Harvesting of the cells was performed as follows: cells were washed twice with sterile 
Phosphate Buffer Saline (PBS) solution without Calcium and Magnesium, and 
subsequently incubated with trypsin/EDTA solution (0,05% trypsin, 0,02% EDTA in PBS 
1x, EuroClone) at 37°C. After the detachment of the cells, trypsin was inhibited by 
addition of FBS containing growth medium. Trypsin/EDTA was removed by 
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centrifugation, cells were diluted to the desired concentration in growth medium and 
replated. 
For long-term storage, cells were frozen and stored in liquid nitrogen. Cells were harvested 
by trypsinization and 1 million cells was resuspended in 1 ml of freezing solution, 
composed by 90% FBS (Hyclone) and 10% dimethyl-sulphoxide (DMSO), and placed in 
cryovials (Nalgene). Vials were placed immediately at -80°C in a cribox, and after 
overnight storage transferred to liquid nitrogen. 
 
4. Cells transfection and generation of a stable clone 
4.1 Transfection of the C2C12 cell line by microporation 
Microporation is a transfection technique that uses a gold-plated pipette tip as an 
electroporation device. Electroporation is an effective technique for transfection in which 
an electric field is applied to increase the permeability of the cell membrane, inducing the 
formation of micro-pores. The pores, or "electropores", allow the passage of molecules 
(such as nucleic acids), ions and water from one side to the other of the plasma membrane. 
After electroporation, cells are able to spontaneously close the pores and continue growing. 
The pore formation is a very rapid event that takes about 1 second, while pore closure 
takes a few minutes. Amplitude of the electric pulses, their duration, their number and the 
interval between pulses are parameters that can be varied to optimize the protocol, until a 
threshold is reached, beyond which the diameter of pores increases and the total area of the 
pores is too large to allow repair, creating an irreversible damage to the cell. During 
electroporation the applied electric field causes the passage of a current flow through the 
cell, and this may cause considerable heating and subsequent cell death. Microporation, in 
contrast to conventional electroporation, allows the generation of a more uniform electric 
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field with minimal heat production, metal ion dissolution, pH variation and oxide 
formation.  
Microporation of C2C12 cells was carried out using the Neon transfection system 
microporation kit (MPK10096, Invitrogen), specific for mammalian cells, in accordance 
with the manufacturer instructions. C2C12 transfection efficiency with microporation 
technique reaches 98%, in contrast to 40% efficiency obtained by cationic lipid 
transfection. 
C2C12 cells were detached from the plate and 1x106 cells were resuspended in 100 µl of 
resuspension buffer R (MPK10096, Invitrogen). DNA was then added to the cells 
according to these concentrations: 
o 40 ng/µl of pBABE-HAN1FLAG 
o 40 ng/µl of pCS2-ICV-6MT 
o 8 ng/µl Firefly luciferase Notch reporter pGa981-6 
o 0,4 ng/µl Renilla luciferase pRL-TK 
Upon the addition of 4 ml Electrolytic buffer E (MPK10096, Invitrogen), the 
microporation tube was inserted into the pipette station to form the microporation unit. The 
cell/DNA mixture was uploaded into the microporation gold-tip. The microporation 
parameters, previously optimized for the best transfection efficiency, were set as this: 
o Pulse voltage: 1100 V 
o Pulse width: 30 ms 
o Pulse number: 2 
Following microporation, samples were transferred to pre-heated culture medium and 
plated according to the experimental conditions. Cells were allowed to recover overnight 
and the following day the culture medium was changed, or the experiment performed. 
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4.2 Generation of a stable C2C12 clone expressing the human receptor Notch1 
To obtain a C2C12 cell line stably expressing the receptor Notch1, a total of 1x106 C2C12 
cells were transfected with 4 µg of pBABE-HAN1FLAG plasmid via microporation, as 
previously described. Twenty-four hours after transfection, cells were detached from the 
plate and diluted to 4 different concentrations (1:5, 1:10, 1:15 and 1:20) to avoid that they 
reach confluency before selection. Forty-eight hours after transfection we began selection 
of pBABE-HAN1FLAG expressing cells, adding 1.5 µg/ml Puromycin to the growth 
medium, according to the concentration previously established during the killing curve. A 
killing curve is a dose-response experiment where the cells are subjected to increasing 
amounts of antibiotic to determine the minimum antibiotic concentration needed to kill all 
the cells over the course of one week. After 7 days of selection, about 100 Puromycin 
resistant clones were present on the transfected plates, while in the control non-transfected 
plate, all cells were dead. To obtain subclones derived from a single cell, 40 clones were 
trypsinized, picked from the plates with the aid of a pipette tip, counted and resuspended at 
a concentration of 1 cell in 100 µl. 100 µl of cell suspension were then plated in each well 
of a 96 well plate. Each clone was plated 12 times. The next day, 100 µl of fresh medium 
were added to each well and then the medium was changed every 2 days for 10-15 days. 
Clones that survived expansion were trypsinized and expanded at first in 48 well plate, 
then 24 well plate, 6 well plate and finally into a 10 cm cell culture dish. An aliquot of the 
survived clones was analyzed by western blot for the presence of the Notch1 protein, while 
the remaining cells were frozen in liquid nitrogen. Based on the results of the western blot, 
cells that expressed the Notch1 receptor were thawed and subsequently tested in a Notch 
reporter transactivation assay for their ability to signal. 
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4.3 RNA interference 
To perform RNA interference (RNAi) in C2C12-derived and OP9-derived cells we 
transfected the cells with RNA oligonucleotides (oligos) through the use of artificial lipid 
vesicles, called liposomes (Lipofectamine RNAi Max, Invitrogen). Lipofectamine RNAi 
Max is a cationic lipid, optimized for RNA molecules transfection. Cationic lipids form an 
aggregate of vesicles around the DNA or RNA molecule, establishing electrostatic bonds 
with the negative charges of the nucleic acid itself. Cationic liposomes are then able to 
interact with negative charges present on the plasma membrane and facilitate the entry of 
the nucleic acid into the cell.  
To perform RNAi, on day 1 cells were detached from the plate, counted and resuspended 
in fresh medium at a concentration of 0,5x105 cells/ml. Two ml of cell suspension (for a 
total of 1x105 cells) were transferred in a sterile 15 ml falcon. 500 µl of transfection mix 
were then added dropwise to the cell suspension, and the content of the falcon was plated 
in 1 well of a 6 well plate. 
Transfection mix was prepared as follows: 
o mix 1: 5 µl of Lipofectamine RNAi MAX (Invitrogen) were added to 250 µl of 
Opti-MEM fresh medium (Gibco) 
o mix 2: Oligos at the desired final concentration (concentrations and sequences are 
specified in Materials and methods section 2.4, Table 3) were added to 250 µl of 
Opti-MEM fresh medium (Gibco) 
o Transfection mix: mix1 was added to mix2 and incubated 20 minutes at room 
temperature before use 
RNA interfered cells were then transferred in a humidified incubator at 37°C and 5% CO2 
for 24 hours. On day 2 medium was changed and transfection was repeated as described 
before on adherent cells. On day 3 medium was changed again or cells were detached, 
counted and plated at the desired concentration depending on the experimental condition; 
cells were used to perform the experiment on day 4. 
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5. Molecular biology, biochemical and immunostaining procedures 
5.1 RT qPCR 
Quantitative real time polymerase chain reaction (RT qPCR) is a technique used to amplify 
and simultaneously quantify a targeted DNA molecule. It enables both detection and 
quantification (as absolute number of copies or relative amount) of one or more specific 
sequences in a nucleic acid sample. TaqMan® chemistry uses a fluorogenic probe to 
enable the detection of a specific PCR product as it accumulates during PCR cycles. 
Total RNA was isolated from 1x106 or 1x105 plated cells using RNeasy Mini kit (Quiagen) 
in accordance with the manufacturer’s instructions. Reverse transcription was performed 
with SuperScript VILO cDNA Synthesis Kit (Invitrogen) starting from 1 µg RNA. RT 
qPCR was performed using TaqMan chemistry (Invitrogen) employing a 7500 Real-Time 
PCR System instrument (Applied Biosystems), according to the manufacturer’s 
instructions. Probes were purchased from Applied Biosystems as previously described in 
Reagents section. The results were normalized on the expression of the housekeeping gene 
GAPDH. The 2-delta delta ct method was employed to analyze the relative changes in 
gene expression (Livak & Schmittgen, 2001). 
 
5.2 Western Blotting 
To obtain a proteic lysate, cells were placed on ice, washed twice with cold PBS and lysed 
in JS buffer directly in the cell culture plates using a cell-scraper. Lysates were allowed to 
incubate for 15 minutes and then clarified by centrifugation at 16,000 rpm for 15 minutes 
at 4°C in a 5415 R Eppendorf centrifuge. Protein concentration in the samples was 
measured using the BCA Protein Assay Reagent KIT (Pierce), using as standard bovine 
serum albumin (BSA), following manufacturer’s instructions. Desired amounts of proteins 
were loaded onto precast polyacrylamide gels for electrophoresis (Biorad) together with a 
prestained protein molecular weight marker (Biorad). Gels were run at 200V in Running 
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buffer. Proteins were transferred in Western transfer tanks (Biorad) onto nitrocellulose 
(Schleicher and Schuell) using Western Transfer buffer at 100V for 1 hour. Membranes 
were stained with Ponceau (Sigma) to determine the efficiency of protein transfer. 
Membranes were blocked 1 hour in 5% low fat milk in TBS 1% Triton X-100 (TTBS) (for 
incubation with polyclonal antibodies) od in 5% BSA in TTBS (for incubation with 
monoclonal antibodies). After blocking, filters were incubated with the primary antibody, 
diluted in the same solution as blocking, in for 1 hour at room temperature, or overnight at 
4°C, followed by three washes of 10 minutes each in TTBS and then incubated with the 
appropriate horseradish peroxidase-conjugated secondary antibody diluted in TTBS for 1 
hour. After incubation with the secondary antibody, the filter was washed 3 times in TTBS 
as previously described and the bound secondary antibody was revealed using either the 
SuperSignal West Pico Chemiluminescent Substrate (Pierce) or the SuperSignal West 
Femto Chemiluminescent Substrate (Pierce), and the Chemidoc system (Biorad). 
 
5.3 Immunofluorescence 
Cells were detached, counted and plated on 13 mm glass coverslips (coated with 15 µg/ml 
Poly-D-lysine at 37°C for 30 minutes) at a density of 1x104 cells/coverslip. 24 hours later, 
cells were fixed at 4°C in 4% paraformaldehyde (in 1X PBS) for 10 minutes, washed with 
PBS and permeabilized and blocked in a solution of 0.05% Triton X-100, 1% BSA and 10% 
serum in 1X PBS for 1 hour at room temperature. Cells were then incubated overnight at 
4°C in a humidified chamber with the primary antibody diluted in 0.05% Triton X-100, 1% 
BSA in TBS. The following morning cells were washed 3 times with 0.05% Triton X-100, 
1% BSA in TBS and incubated for 1 hour with fluorescently labeled secondary antibodies 
(Amersham) diluted in TBS. After 3 washes with TBS, nuclei were DAPI-stained for 5 
minutes and cells washed again 2 times with H2O. Coverslips were immediately mounted 
with mowiol and examined under a wide-field fluorescence 86microscope (Olympus) with 
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the help of the associated software MetaMorph (Molecula Devices). Images were further 
processed with the ImageJ software. 
 
5.4 FACS analysis 
Flow cytometry assay is a technique for counting, examining and sorting cells suspended 
in a stream of fluid. It allows simultaneous multi-parametric analysis of the physical and/or 
chemical characteristics of single cells flowing through a fluidic, optical and electronic 
detection apparatus. A beam of laser light of a determined single wavelength is directed 
onto a hydro-dynamically focused stream of fluid. Each suspended cell pass through a 
small nozzle, one at time, and scatters the light in a certain way; moreover fluorescent 
chemicals found in the cell or attached to the cell membrane can be excited into emitting 
light at a higher wavelength than the light source. The detectors pick up this combination 
of scattered and fluorescent light and, by analyzing fluctuations in brightness at each 
detector (one for each fluorescent emission peak), it is then possible to derive information 
about the physical and chemical structure of each individual cell. FSC (forward scatter) 
correlates with the cell size and SSC (side scatter) depends on the inner density and 
granularity of the cell (i.e. shape of the nucleus, the amount and type of cytoplasmic 
granules or the membrane roughness).  
The FACS-Calibur flow cytometer (BD Biosciences), used in this work, employs a dual-
laser technology, an air-cooled argon laser and a red diode laser, that allows flexibility and 
sensitivity for multicolor analysis (Figure 2.1). The 488 nm excitation laser allows the 
detection of green (FL1: FITCH, Alexa Fluor 488), yellow (FL2: PE, PI) and red 
fluorochromes (FL3: PE-Cy5, PerCP, PE-Cy7), while the 635 nm excitation laser allows 
the detection of other red fluorochromes, such as APC and Alexa Fluor 647 (FL4) (Figure 
2.1).  
Data generated by flow-cytometers were analyzed using FlowJo software. Data were 
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plotted in a single dimension, to produce a histogram, and mean fluorescence of the 
histogram was calculated and compared between samples. 
 
 
Figure 2.1 BD FACSCalibur Optical Path Configuration 
Schematic representation of lasers and fluorescence detectors of the FACS-Calibur flow 
cytometer (BD Biosciences) [adapted from BD Biosciences website]. 
 
5.5 Dll1 surface levels measurement 
To measure Dll1 surface levels, OP9-Dll1 cells (KD or not) were detached from the plate 
and counted. 1x105 cells were resuspended in 50 µl of cold Opti-MEM (Gibco) containing 
10% BSA, and placed in a 1,5 ml eppendorf on ice. Cells were stained 1 hour at 4°C by 
adding to the cell suspension 50 µl of Opti-MEM (Gibco) containing anti Dll1 HMD1-3 
Alexa Fluor 647 Biolegend, for a final concentration of 2 µg/ml in 100 µl final volume. 
After staining cells were washed twice in cold PBS, resuspended in cold PBS containing 2% 
BSA, and immediatedly analyzed using FACS-Calibur flow cytometer (BD Biosciences). 
R E P R O D U C I B L E
Performance and simplicity 
when it counts The BD FACSCalibur is a fully integrated multiparameter 
system that has the performance and sensitivity to ensure 
objective and reproducible results vital to laboratories 
worldwide.
Optical path configuration
Flow cytometry has evolved rapidly to incorporate the use 
of multiple fluorochromes to effectively identify and isolate 
subset populations in a single sample. This maximizes the 
information gained from limited samples and makes the 
assays more cost effective.
The first system to provide standard multicolor analysis 
capabilities with the use of dual-laser technology, interbeam 
compensation, and an alignment free optical design, the 
BD FACSCalibur system ensures high sensitivity, minimal 
compensation, and maximum flexibility in choice of 
fluorochromes. 
This high performance system is a valued tool worldwide for 
routine cell analysis, assay development, verification, and 
identification of cellular populations of interest.














A growing number of flow cytometry–based assays depend on 
rare-event detection. For example, in the characterization of 
subpopulations of stem cells, millions of cells are analyzed to 
achieve a statistically significant sampling of the subset of interest. 
Advanced applications like this require a flow cytometer capable 
of high-speed analysis. The BD FACSCalibur system features a 
multiparameter triggering system that allows a user to accelerate 
the analysis by electronically eliminating events from onboard 
processing.
A  Region R3 defines basophils and region R4 defines CD123+ DCs 
(0.14% of total).
B Region R5 defines CD11c+ DCs (0.21% of total).
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6. Biological and biochemical assays 
6.1 Notch reporter transactivation assay 
Reporter gene technology is often used to monitor cellular events associated with signal 
transduction and gene expression. The term ‘reporter gene’ is used to define a gene with a 
phenotype easily distinguishable from endogenous proteins, such as ability to generate 
luminescence. The reporter unit is composed by a promoter followed by the reporter gene; 
the promoter binds transcription factors that are activated in response to a signalling 
cascade. Activation of the promoter allows expression of the reporter gene, which in turn 
provides information on the activity of the signal transduction pathway.  
To monitor activation of Notch signalling pathway, we chose as reporter unit the plasmid 
pGA981-6, encoding the reporter gene Firefly luciferase, an enzyme that catalyzes the 
oxidation of a substrate with subsequent luminescence emittance (figure 2.2). Upstream of 
the reporter gene are located 6 binding sites for the transcription factor CSL followed by 
the minimal promoter of the ß-globin. To normalize reporter gene activity on transfection 
efficiency we cotransfected, together with the reporter gene, the plasmid pRL-TK, 
encoding for the constitutively expressed Renilla luciferase, another enzyme belonging to 
the luciferase family (Figure 2.2). 
To perform the Notch reporter transactivation assay, 1x106 C2C12 or C2C12-Notch1 cells 
(KD or not) were transfected via microporation, as previously described, with the Firefly 
luciferase construct and the Renilla luciferase construct. 1x104 transfected cells were plated 
in each well of a 96-well plate. For each experimental condition, 8 technical replicas were 
performed. In order to be able to process more samples in parallel, we were able to 
downscale the initial co-culture procedure (originally performed in a 24 well plate) into a 
96 well plate assay. 
24 hours after transfection, 1x104 OP9 or OP9-Dll1, OP9-Dll4, OP9-Jagged1 and OP9-
Jagged2 cells (KD or not) were plated on top of C2C12-Notch1 cells. After 24 hours 
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coculture, cells were lysed and luciferase activity was detected with Dual-Luciferase 
Reporter Assay System KIT (Promega) according to the manufacturer’s instructions. When 
specified, 1 µg/ml DAPT (D5942 Sigma) was added to C2C12-Notch1 cells 16 hours prior 
to coculture; treatment was maintained until the end of the experiment. 
 
 
Figure 2.2 Bioluminescence reactions catalyzed by Firefly and Renilla luciferase. 
Firefly luciferase is a 614 kD monomeric protein that is not posttranslational modified. For this 
reason it is able to function as a reporter immediately after translation. Firefly luciferase emits 
photons through the oxidation of the beetle luciferin substrate through a reaction that requires ATP, 
Mg2+ and O2. Renilla luciferase is a 36 kD monomeric protein which also does not need 
posttranslational modifications to perform its enzymatic activity. The luminescence reaction 
catalyzed by Renilla luciferase employs O2 to oxidize the substrate Coelenterazine. 
 
6.2 Dll1 internalization assay  
The Dll1 endocytosis assay that we set up in OP9-Dll1 cells allowed us to follow the 
internalization of the ligand in time, at the early steps of the endocytic process. The assay 
permits to follow both receptor mediated Dll1 endocytosis (following stimulation with a 
preclusterd recombinant N2Fc protein that should mimic the physiological conditions of 
Notch extracellular domain endocytosis) and constitutive endocytosis (through the use of a 
fluorochrome conjugated antibody anti-Dll1).  
Subconfluent OP9-Dll1 cells were detached from the plate by mild trypsinization (0,025% 
trypsin), resuspended at 5x104 cells /50 µl of pre warmed Opti-MEM containing 5% FBS 
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and transferred into a well of a 2 ml volume V-bottom Corning 96 well storage system 
plate (Sigma). Cells were then allowed to equilibrate at 37°C for 30 minutes. 
Internalization was performed at 37°C for 2, 4 and 6 minutes by adding 50 µl of 2x 
internalization mix to the cell suspension.  
2x internalization mix consisted of: 
o 2 µg/ml Notch2-Fc/chimera (N2Fc) (N9161 Sigma) preclustered for 15 minutes at 
4°C with 20 µg/ml anti human IgG Alexa Fluor 647 (A-21445 Invitrogen) in Opti-
MEM 
OR  
o 4 µg/ml anti Dll1 Alexa Fluor 647 (HMD1-3, Biolegend) in Opti-MEM 
Internalization was stopped by transferring cells on ice and washing them twice with cold 
PBS. Surface stain was removed by treatment with 0.5 µg/ml Pronase (P6911 Sigma) in 
PBS, 30 minutes at 4°C. The Pronase reaction was blocked by the addition of 500 µl Opti-
MEM containing 5% FBS. Samples were then washed in cold PBS and resuspended in 400 
µl of PBS 2% BSA and immediately analyzed with BD FACSCalibur flow cytometer.  
 
6.3 Dll1 internalization assay analysis 
For each experimental condition of the Dll1 endocytosis assay, two different samples were 
analyzed: one sample not treated with pronase, which represents the total fluorescence, 
given by the surface bound Dll1 and the internalized Dll1 (TOTAL), and one sample 
treated with pronase, which represents the internalized fluorescence, since the Dll1 on the 
membrane had been depleted by pronase treatment (INTERNALIZED). After analysis 
with the flowJo software (version 9.4), the quote of Dll1 bound to the membrane at each 
experimental timepoint (BOUND) is calculated subtracting the INTERNALIZED 
fluorescence from the TOTAL fluorescence. The ratio between INTERNALIZED and 
BOUND fluorescence was determined for each time point. This data was used to obtain the 
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internalization curve (x-axis: time, y-axis: INTERNALIZED/ BOUND). Internalization 
rate constants (Ke) were extrapolated from the internalization curves (at early time points: 
2, 4 and 6 min) and correspond to the slope of the best-fitting curve. All the analysis and 
statistics, following extrapolation of the fluorescence values by flowJo, were performed 
with the Excel software. 
 
6.4 Dll1 recycling assay 
As a first approach to measure Dll1 recycling, we tried to modify the internalization assay 
previously described. OP9-Dll1 cells were detached and 5x104 cells were resuspended in 
50 µl of pre warmed Opti-MEM containing 5% FBS + 50 µl of 2x  internalization mix. 
Internalization was performed at 16°C for 60 minutes. Internalization mix 2x was prepared 
as follows: 
o 2 µg/ml N2Fc preclustered for 15 minutes at 4°C with 20 µg/ml anti human IgG not 
conjugated, in Opti-MEM 
OR  
o 4 µg/ml anti Dll1 not conjugated in Opti-MEM 
OR 
o Opti-MEM 
Treatment with 0.5 µg/ml Pronase (P6911 Sigma) in PBS, 30 minutes at 4°C was 
employed to remove surface stain. Pronase reaction was blocked by the addition of Opti-
MEM containing 5% FBS. Samples were then washed in cold PBS, resuspended in Opti-
MEM containing 5% FBS and released at 37°C for 2, 5, 10 and 30 minutes. Recycling was 
stopped by transferring cells on ice. Membrane staining was performed 1h at 4°C with 2 
µg/ml anti Dll1 Alexa Fluor 647. Samples were analyzed for Dll1 surface staining with BD 
FACSCalibur flow cytometer. 1 µg/ml cycloheximide (Sigma) was added to OP9-Dll1 
cells 3 hours prior to detachment and maintained until the end of the experiment. 
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6.5 Lipid rafts extraction in sucrose gradient 
Lipid microdomain isolation in OP9-Dll1 cells was performed according to (Heuss, et al., 
2008) and (Shah, et al., 2012) with modifications. 
Eighty % confluent 10 cm plates of OP9-Dll1 (KD or not) were transferred on ice, washed 
twice with cold PBS and lysed in a total volume of 400 µl/plate of buffer A (20 mM Tris, 
pH 7.5, 150 mM NaCl) containing 30 µl/ml of protease inhibitor cocktail (Calbiochem) 
and 1% in weight of Brij58 (Sigma). Cells were removed from the plate with the help of a 
cell scraper and quantified using the BCA Protein Assay Reagent KIT (Pierce), following 
manufacturer’s instructions.  
In the meantime the tubes containing the 5%-30% continuous sucrose gradient were 
produced using the Biocomp Gradient Master: 
o Prepare a 5% and a 30% sucrose solution 
o Level the magnetic platform with a leveller 
o Place the tube (Polypropylene, Thinwall, 5.0 mL, 13 x 51 mm, Beckman Coulter) 
in the holder and mark the middle level 
o Add 3 ml of the 5% sucrose solution to the tube 
o With the help of a 2.5 ml syringe and a long needle, add ≈ 2 ml of the 30% sucrose 
solution underneath the 5% layer until the separation front comes to the marked 
line 
o Put on the cap and remove excess liquid 
o Put the holder containing the tubes into the platform and run the 5%-30% program 
200 µg of lysates were loaded on the top of the gradient. The gradient was then subjected 
to centrifugation for 16 hours at 4°C at 37000 rpm in a swing out 55ti Rotor (Beckman 
Coulter). Thirteen fractions of 400 µl each were collected from the top of the gradient. 30 
µl of each fraction were separated by SDS page, transferred to a nitrocellulose membrane 




Chapter 3  
RESULTS 
 
1. Characterization of cell lines to study the role of Eps15 and Eps15L1 in 
Notch signaling regulation 
1.1 The OP9-Dll1 and C2C12 model system 
To study the biology of Notch ligands and receptors in vitro it was necessary to employ a 
co-culture cell model system in which a signal-sending cell, expressing a Notch ligand, and 
a signal-receiving cell, expressing a Notch receptor, come into close contact.  
As a model for the signal-sending cell, we used the bone marrow, stromal, murine cell line 
OP9, overexpressing the Notch ligand Dll1 (OP9-Dll1). The OP9-Dll1 cell line was 
generated in 2002 by Schmitt and Zuniga-Pflucker as tool to study the role of Dll1 in 
thymocyte development in vitro (Schmitt & Zuniga-Pflucker, 2002). Since then, this cell 
line has been used in numerous studies to investigate Notch ligand regulation and signaling, 
since it allows the technical development of biological and biochemical in vitro assays (de 
Pooter & Zuniga-Pflucker, 2007; Gravano & Manilay, 2010; Heuss, et al., 2008; Heuss, et 
al., 2013; Holmes & Zuniga-Pflucker, 2009; Mohtashami et al., 2010; Shah, et al., 2012; 
Song, et al., 2008). 
Before starting to set-up the co-culture model system, we wanted to confirm Dll1 
expression in the OP9-Dll1 cells. To do so, we performed an immunofluorescence (IF) 
analysis of Dll1. As expected, OP9-Dll1 cells overexpressed the ligand Dll1 compared to 
the control OP9 cells (Figure 3.1). 
As model for the signal-receiving cell, we used the murine, myoblast cell line C2C12, a 
subclone of the myoblast cell line established by Yaffe and Saxel (Yaffe & Saxel, 1977), 
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that has been reported to expresses the Notch2 receptor (Ono et al., 2007). Since an 
antibody against the Notch2 receptor was not available, we decided to verify the levels of 
Notch2 transcript in C2C12 cells by QPCR analysis. The levels of Notch2 mRNA in 
C2C12 cells were found to be increased 2-fold compared to those of the housekeeping 
gene GAPDH (Figure 3.2). 
 
 
Figure 3.1 OP9-Dll1 cells overexpress the Notch ligand Dll1 compared to control OP9 cells. 
Immunofluorescence photographs of control OP9 cells (A) compared to OP9-Dll1 cells (B). Cells 
(1,5 x 104) were plated on glass coverslips 24 hours before fixation. The primary antibody, anti-
Dll1, was detected with a secondary anti-hamster Alexa-Fluor 568 antibody. Scale bar corresponds 
to 10 µm. Photographs are representative of three repeats. 
 
1.2 OP9-Dll1 cells and C2C12 cells express different amounts of Notch ligands and 
receptors 
Most cell lines express both Notch ligands and receptors; this is something we wanted to 
avoid in our model system, since cis interactions between ligand and receptor in the same 
cell could lead to misinterpretation of our data. Therefore, we decided to assess by QPCR 
analysis the mRNA levels of all Notch ligands and receptors in OP9-Dll1 and C2C12 cells. 
This was done to ensure that OP9-Dll1, as signal-sending cells, expressed mainly Notch 
ligands, and C2C12, as signal-receiving cells, expressed mainly Notch receptors. Using 




ligands and receptors in both OP9-Dll1 and C2C12 cells, normalizing to the housekeeping 
gene GAPDH. As expected, we found that in OP9-Dll1 cells, the Dll1 transcript was 
expressed at 50-fold higher levels than GAPDH, while in C2C12 cells it was virtually 
absent. Dll3 and Dll4 transcripts were undetectable in both cell lines. In contrast, Jag1, but 
not Jag2, was detectable at significant levels in OP9-Dll1 cells, while in C2C12 cells these 
ligands were barely detectable. Considering Notch receptors, we observed that Notch1 and 
Notch4 transcripts were absent or barely detectable both in OP9-Dll1 cells and in C2C12 
cells. Small amounts of Notch2 and Notch3 transcript were detected in OP9-Dll1 cells, 
while in C2C12 cells, we observed levels of endogenous Notch2 transcript 2-fold higher 
than the housekeeping gene GAPDH (Figure 3.2). 
 
 
Figure 3.2 OP9-Dll1 and C2C12 cells express different amounts of Notch ligands and 
receptors. 
Bar graph depicting the relative mRNA levels of all the Notch ligands (Dll1, Dll3, Dll4, Jag1, Jag2) 
and receptors (Notch1, Notch2, Notch3, Notch4) in OP9-Dll1 (gray) and C2C12 (black) cell lines 
as determined by QPCR. Values were normalized to GAPDH. The y-axis has been compressed for 


























































1.3 OP9, OP9-Dll1 and C2C12 cells express comparable levels of Eps15 and Eps15L1 
After we verified the suitability of our model system, we decided to assess by WB analysis, 
the levels Eps15 and Eps15L1 expression in the two cell lines. This was done to 
understand if the model system could be employed to study the roles of Eps15 and 
Eps15L1 in Notch signaling by downregulation of the proteins or by overexpression. 
We found that Eps15 and Eps15L1 proteins were expressed at comparable levels in OP9, 
OP9-Dll1 and C2C12 cells (Figure 3.3A and B).  
  
 
Figure 3.3 OP9, OP9-Dll1 and C2C12 cells express comparable levels of Eps15 and Eps15L1. 
WB analysis of Eps15 and Eps15L1 expression in OP9 (A), OP9-Dll1 (A) and C2C12 (B) cells. 
Positive controls for western blotting were adult mouse brain extract (Mouse brain) and human 
HeLa cells (HeLa). For each sample, 10 µg of total protein lysate were resolved by SDS-Page and 
blotted onto a nitrocellulose membrane. All samples were loaded on the same gel. Specific 
antibodies, as indicated on the right, were used to probe the membrane. Black arrows indicate two 
bands, at 150 kDa and 125 kDa, for Eps15 and three bands, at 130 kDa, 110 kDa and 70 kDa, for 
Eps15L1. These molecular wheights differ from those predicted from the amino acid sequence of 
Eps15 and Eps15L1, which are respectively 98 KDa and 99 KDa. For Eps15, the higher band 
represents the primary product of mRNA translation, while the lower band is possibly a 
degradation product or the result of alternative splicing/incomplete mRNA translation. For 
Eps15L1, the higher band represents the primary product of mRNA translation, while the minor 
bands are the result of alternative splicing. Additional bands, not marked by arrows, are nonspecific 












































2. Set-up and characterization of the Notch reporter transactivation 
assay 
2.1 Notch reporter activation in C2C12 cells is efficient and reproducible but is not 
increased by transient transfection of Notch1 
After having characterized the OP9-Dll1/C2C12 co-culture cell model system, we set-up a 
Notch transactivation, luciferase reporter assay to act as a readout of Notch activity in the 
signal-receiving C2C12 cells. C2C12 cells were transiently co-transfected with a Notch-
responsive, firefly, luciferase reporter construct that measures Notch signaling activation, 
and a control reporter construct that constitutively expresses renilla luciferase, as an 
internal control for transfection efficiency (C2C12-Luc). When these C2C12-Luc cells are 
co-cultivated with the OP9-Dll1 signal-sending cells, the Notch receptor (in C2C12-Luc) is 
activated by the Dll1 ligand (in OP9-Dll1) and the NICD is released. The NICD then 
translocates to the nucleus and activates transcription of the Notch luciferase reporter gene. 
To test the efficiency and reproducibility of the reporter assay, we co-cultivated, for 24 
hours, OP9 control cells that do not express Dll1 ligand with: i) C2C12-Luc cells, to 
determine the background noise in our model system, or with ii) C2C12-Luc cells that had 
been transiently transfected with NICD to bypass ligand-dependent Notch activation. This 
experiment allowed us to assess the theoretical signal-to-noise ratio of the luciferase 
reporter assay. From our data, we could observe a clear and reproducible activation of the 
luciferase reporter gene in the C2C12-Luc cells transfected with NICD (Figure 3.4, gray 
bars).  
We then proceeded to co-cultivate C2C12-Luc cells with OP9-Dll1 cells, to measure 
ligand-dependent activation of endogenous Notch receptor. We observed a modest, but 
statistically significant activation of endogenous Notch (approximately 2.5-fold; Figure 3.4, 
compare ‘NT’ bars). Since we require a model system that would allow us to observe a 
reduction in Notch activation (as would be expected upon KD of Eps15 or Eps15L1), this 
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level of activation was not sufficient for our experiments. To obtain a higher level of Notch 
activation, we thought to increase receptor levels by transiently overexpressing Notch1 in 
C2C12 cells 24 hours prior to co-culture. For this purpose, we used a pBABE-
HAN1FLAG construct encoding full-length human Notch1 receptor, tagged with a C-
terminal FLAG-tag and an N-terminal HA-tag. However, we did not score any difference 
between this and the previous co-culture condition, indicating that the ectopically 
expressed tagged-Notch1 receptor was either not functional or not expressed correctly 
(Figure 3.4, compare black bars). 
 
 
Figure 3.4 Transient transfection of Notch1 in C2C12 cells does not increase Notch reporter 
activity over background levels. 
C2C12 cells were transiently transfected with the Notch-reporter firefly luciferase construct and the 
renilla luciferase control construct (C2C12-Luc). At the same time, C2C12-Luc cells were further 
transiently transfected with an NICD construct (NICD), with a Notch1 full-length construct 
(Notch1) or with no construct (NT). 24 hours after transfection, C2C12-Luc cells were co-cultured 
for 24 hours with OP9 (gray bars) or OP9-Dll1 (black bars) cells, before measuring luciferase 
activity. The bar graph depicts the relative luciferase activity of the Notch-reporter firefly luciferase 
normalized to the activity of renilla luciferase. Statistical significance was determined using the 
Student’s T-test: **= p < 0.01, *** = p < 0.001.Values are expressed as the mean ± SEM. Three 
independent experiments were performed for the NICD condition. Six independent experiments 


























To understand why the ectopically expressed Notch1 receptor was not active in the 
luciferase reporter assay, we performed a WB analysis of C2C12-Luc cells at 24, 48 and 
72 hours after transfection with the pBABE-HAN1FLAG construct. The pBABE-
HAN1FLAG construct encodes a Notch1 receptor HA-tagged at the N-terminal, and 
FLAG-tagged at the C-terminal. The full-length precursor of the receptor (300 kDa) is 
detectable by WD either with an anti-HA antibody or with an anti-FLAG antibody. After 
processing of the receptor, the N-terminal domain (180 kDa) is detectable with the anti-HA 
antibody, while the C-terminal fragment (120 kDa) is detectable with the anti-FLAG 
antibody. Following Notch activation it would also be possible to detect the NICD 
fragment (80 kDa) with the anti-FLAG antibody. 
Using the anti-HA antibody, we detected a smeared band of approx. 150 – 200 kD at 24 
hours after transfection, but not at 48 and 72 hours (Figure 3.5). This data suggested that 
the transiently transfected Notch1 is not correctly processed and that the expression of the 
protein decays after 24 hours post-transfection, indicating that the protein is not expressed 
during the timeframe of the co-culture assay. 
 
Figure 3.5 Uncorrect processing and rapid loss of Notch1 protein upon transient transfection 
in C2C12 cells. 
WB analysis of C2C12-Luc cells not transfected (C2C12) or transiently transfected with the HA-
Notch1-FLAG construct at 24 (24h), 48 (48h) and 72 (72h) hours post-transfection. For each 
sample, 10 µg of total lysate were separated by SDS-PAGE and blotted onto a nitrocellulose 
membrane. Specific antibodies, as indicated on the right, were used to probe the membrane. 














2.2 Generation and characterization of a stable C2C12 clonal cell line overexpressing 
Notch1 receptor 
Since expression of the transiently transfected Notch1 receptor in C2C12 cells was not 
maintained for sufficient time to allow efficient transactivation of the reporter, we decided 
to generate a stable cell line that constitutively expressed the receptor. We transfected 
C2C12 cells with the pBABE-HAN1FLAG construct; 48 hours after transfection we 
selected the cells with 1.5 mg/ml of puromycin. After 7 days of selection, we picked and 
expanded 40 single clones. Nine clones survived clonal expansion and were assessed for 
tagged-Notch1 expression by WB analysis with an anti-HA and an anti-FLAG antibody. 
Four clones (1A, 1B, 2A, 15A) stably expressed the correctly processed HA-Notch1-
FLAG, with the expected approximate MW of ≈ 300 KDa for the full-length form (Figure 
3.6, black arrow), and ≈ 180 KDa and ≈ 120 KDa respectively for the N- and C-terminal 
portions (Figure 3.6, asterisks). One clone (11A) expressed HA-Notch1-FLAG that was 
not processed correctly, possibly due to degradation or partial translation. The remaining 
clones did not express HA-Notch1-FLAG (Figure 3.6). 
 
 
Figure 3.6 Generation of a stable C2C12 clone overexpressing Notch1 receptor. 
WB analysis of C2C12-Notch1 clones stably transfected with the HA-Notch1-FLAG construct 
(1A, 1B, 2A, 11A, 11B, 15A, 15B, 16A, 16B). C2C12 cells transfected with an empty vector (EV) 
























and blotted onto a nitrocellulose membrane. Specific antibodies, as indicated on the right, were 
used to probe the membrane. Vinculin was used as a loading control. The black arrow indicates the 
full-length form of the receptor, the asterisks indicate the N- and C-terminal portions respectively. 
 
We then chose three clones with different levels of tagged-Notch1 expression (clone 1A, 
2A and 15A) and tested them in the Notch transactivation reporter assay. Of these, clone 
15A, which displayed the highest level of expression, showed the best induction of the 
Notch reporter upon co-culture with OP9-Dll1 cells (Figure 3.7). The level of Notch 
activity in clone 15A was approx. half of the maximum activation achieved by transfection 
of NICD. 
After validating the efficiency of clone 15A in the co-culture assay, we wanted to verify 
that the expression levels of Eps15 and Eps15L1 proteins did not change following clonal 
expansion of the cells. We performed a WB analysis of total cell lysates and found that 
Eps15 and Eps15L1 proteins were expressed at similar levels in clone 15A cells and in the 
wild-type (WT) C2C12 cells (Figure 3.8).  
Based on these results, we concluded that clone 15A was a suitable model to study the role 
of Eps15 and Eps15L1 in Notch signaling regulation. For sake of clarity, clone 15A is 




Figure 3.7 OP9-Dll1 cells are able to efficiently transactivate Notch signaling in C2C12 cells 
stably overexpressing the tagged-Notch1 receptor. 
C2C12 cells were transiently transfected with the Notch-reporter firefly luciferase construct and the 
renilla luciferase control construct. C2C12 cells were then further transiently transfected with an 
NICD construct (C2C12 NICD), with no construct (NT) or had been stably transfected with a 
tagged-Notch1 full-length construct (C2C12 1A, C2C12 2A, C2C12 15A). 24 hours after reporter 
transfection, transfected C2C12 cells were co-cultured for 24 hours with OP9 (gray bars) or OP9-
Dll1 (black bars) cells, before measuring luciferase activity. The bar graph depicts the relative 
luciferase activity of the Notch-reporter firefly luciferase normalized to the activity of renilla 
luciferase. Values are expressed as the mean ± SEM. Independent experiments were performed as 
























Figure 3.8 C2C12 clone 15A and C2C12 WT cells express comparable levels of Eps15 and 
Eps15L1. 
WB analysis of Eps15 and Eps15L1 expression in C2C12-Notch1 clone 15A (15A) and C2C12 
WT cells (C2C12). For each sample, 10 µg of total protein lysate were separated by SDS-PAGE 
and blotted onto a nitrocellulose membrane. Specific antibodies, as indicated on the right, were 
used to probe the membrane. Vinculin was used as a loading control. 
 
 
2.3 The γ-secretase inhibitor DAPT is able to abolish Notch transactivation in C2C12-
Notch1 cells 
To further verify that the induction of the luciferase reporter in C2C12-Notch1 cells 
following co-culture with OP9-Dll1 was due to ligand-induced activation of the receptor, 
we treated cells with 1 µM of γ-secretase inhibitor DAPT, before (16 hours), and during 
co-culture (24 hours). Co-culture of OP9-Dll1 and C2C12-Notch1 cells, as previously 
shown, induced a significant increase in relative luciferase activity compared to co-culture 
with OP9 cells (Figure 3.9). This increase was significantly reduced after treatment with 
















Figure 3.9 DAPT abolishes Notch transactivation in C2C12-Notch1 cells. 
C2C12-Notch1 cells were transiently transfected with the Notch-reporter firefly luciferase 
construct and the renilla luciferase control construct. 24 hours after reporter transfection, 
transfected C2C12-Notch1 cells were co-cultured for 24 hours with OP9 or OP9-Dll1 cells in the 
presence or absence of the γ-secretase inhibitor DAPT. The bar graph depicts the relative luciferase 
activity of the Notch-reporter firefly luciferase normalized to the activity of renilla luciferase. The 
blue line indicates 100% of the luciferase activity, while the red line indicates 50% of the signal, to 
help visualize changes in luciferase activity. Values are expressed as the mean ± SEM. Three 
independent experiments were performed. Statistical significance between KD and CTR samples 
























3. Eps15 and Eps15L1 do not have a role in the regulation of Notch 
receptor signaling in the signal-receiving cell 
3.1 Validation of the Notch reporter transactivation assay by silencing of the known 
Notch regulators Numb and dynamin in C2C12-Notch1 cells 
Having set-up the Notch transactivation reporter assay, we next assessed whether KD of 
the known Notch regulators, Numb and dynamin, had the expected effects on Notch 
activity in our reporter assay. Numb is a negative regulator of Notch activity (McGill et al., 
2009; McGill & McGlade, 2003; Pece, et al., 2004), therefore silencing Numb should 
result in increased Notch activity. Dynamin, on the other hand, is a GTPase responsible for 
endocytic vesicles pinching from the membrane, and is necessary for Notch signaling in 
both the signal-sending and the signal-receiving cell (Seugnet, et al., 1997). Silencing 
dynamin, therefore, should result in decreased Notch activity. Mammalian genome 
contains three dynamin genes: dynamin1, that is selectively expressed in neurons, 
dynamin2, that is ubiquitously expressed, and dynamin3, that is predominantly expressed 
in the brain and testis (Ferguson & De Camilli, 2012). 
We silenced Numb and dynamin2 in C2C12-Notch1 cells by lipofectamine transfection of 
specific siRNA oligos. As controls, we used a mock transfected sample containing only the 
lipofectamine tranfection reagent, and three different negative control siRNA oligos. Cells 
were then co-cultured with OP9-Dll1 cells to activate Notch, or with OP9 cells as a 
negative control. We found that, in the mock transfected sample, the addition of 
lipofectamine alone to C2C12-Notch1 cells resulted in a 2-fold increase in Notch 
activation compared with untreated cells (Figure 3.10A). This was possibly due to a 
change in composition of the plasma membrane, resulting in a basal activation of Notch 
signaling. Transfection with three different control siRNA oligos, however, did not cause 
any further changes in Notch activation compared with the mock transfected cells (Figure 
3.10A). As expected, Notch reporter activity was increased upon Numb KD and was 
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significantly downregulated upon dynamin2 KD (Figure 3.10A). The efficient 
downregulation of Numb and dynamin2 protein levels following KD was confirmed by 
WB analysis (Figure 3.10B).  
Thus we can conclude that the Notch reporter transactivation assay is a suitable assay to 




Figure 3.10 Notch activation in the signal-receiving cell is dependent on both Numb and 
dynamin2. 
A. Numb or dynamin2 (Dyn2) expression was silenced in C2C12-Notch1 cells by lipofectamine 
transfection of specific siRNAs. Lipofectamine alone (Mock) or three different control siRNA 
oligos (CTR, CTR2, CTR3) were used as controls for KD specificity. 24 hours after the second KD 
round, cells were transiently transfected with the Notch-reporter firefly luciferase construct and the 














































cells were co-cultured for 24 hours with OP9 or OP9-Dll1 cells, before measuring luciferase 
activity. The bar graph depicts the relative luciferase activity of the Notch-reporter firefly luciferase 
normalized to the activity of renilla luciferase. The blue line indicates 100% of the CTR luciferase 
activity, while the red line indicates 50% of the signal, to help visualize changes in luciferase 
activity. Values are expressed as the mean ± SEM. Four independent experiments were performed. 
Statistical significance between KD and CTR samples was calculated using the Student’s T-test: * 
p < 0.05, *** p < 0.001.  
B. Efficiency of Numb and dynamin2 (Dyn2) KD was assessed by WB analysis of the same 
samples shown in A. At the end of the co-culture, samples were lysed and proteins were extracted. 
Proteins were then separated by SDS-PAGE and blotted onto a nitrocellulose membrane. Specific 
antibodies, as indicated on the right, were used to probe the membrane. Vinculin was used as a 
loading control. Blot is representative of four repeats. 
 
 
3.2 Silencing of Eps15, Eps15L1 or both Eps15/Eps15L1 in C2C12-Notch1 cells does 
not alter Notch activation 
After validating the reporter assay, we evaluated the effects of silencing Eps15 and 
Eps15L1 proteins on Notch activation in the signal-receiving cell. We observed no effects 
on Notch reporter activity following KD of Eps15 and Eps15L1, either singly or combined 
(Figure 3.11A). We confirmed these data by repeating the assay with three different siRNA 
oligonucleotides for each protein, to exclude off-target effects. Similar results were 
obtained with all three siRNAs tested, and data were pooled in Figure 3.11A. We also 
confirmed the efficient downregulation of Eps15 and Eps15L1 protein levels after KD by 
WB analysis (Figure 3.11B).  
Based on these data, we can conclude that Eps15 and Eps15L1 do not have a role in the 
regulation of Notch receptor activity in the signal-receiving cell. 
 90 
	  
Figure 3.11 Notch activation in signal-receiving cells is independent of both Eps15 and 
Eps15L1. 
A. Eps15 (15), Eps15L1 (L1) or both Eps15/Eps15L1 (15/L1) were silenced in C2C12-Notch1 
cells by lipofectamine transfection of specific siRNAs. Lipofectamine alone (Mock) and the 
negative control siRNA oligo (CTR) were used as controls for knockdown (KD) specificity. 24 
hours after the second KD round, cells were then transiently transfected with the Notch-reporter 
firefly luciferase construct and a renilla luciferase control construct. 24 hours after reporter 
transfection, transfected C2C12-Notch1 cells were co-cultured for 24 hours with OP9 or OP9-Dll1 
cells before measuring luciferase activity. The bar graph depicts the relative luciferase activity of 
the Notch-reporter firefly luciferase normalized to the activity of renilla luciferase. The blue line 
indicates 100% of the CTR luciferase activity, while the red line indicates 50% of the signal, to 
help visualize changes in luciferase activity. Values are expressed as the mean ± SEM. Five 
independent experiments were performed. Statistical significance between KD and CTR samples 

































B. Efficiency of Eps15 (15), Eps15L1 (L1) and Eps15/Eps15L1 KDs was assessed by WB analysis 
of the same samples shown in A. At the end of the co-culture, samples were lysed and proteins 
were extracted. Proteins were then separated by SDS-PAGE and blotted onto a nitrocellulose 
membrane. Specific antibodies, as indicated on the right, were used to probe the membrane. 
Vinculin was used as a loading control. Blot is representative of five repeats. 
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4. Eps15 and Eps15L1 are key regulators of Notch signaling in the signal-
sending cell 
4.1 Notch activation in the signal-receiving cell is dependent on the presence in the 
signal-sending cell of Mib1, dynamin and clathrin, and independent of AP2  
Since removal of Eps15 and Eps15L1 in the signal-receiving cell did not affect Notch 
activation, we next tested whether their removal in the signal-sending cell could do so. 
First, we verified that KD of known Notch ligand regulators in the signal-sending cell 
affected Notch activation in the signal-receiving cell, as assessed by our transactivation 
reporter assay.  
Initially, we verified in our system the involvement of the E3 ubiquitin ligase Mib1, a key 
regulator of Notch ligand activation and internalization in both D. melanogaster and 
mammalian cells (Itoh, et al., 2003; Koo, et al., 2005; Song, et al., 2008). As expected, KD 
of Mib1 in OP9-Dll1 cells completely abolished Notch transactivation in the signal-
receiving C2C12-Notch1 cells (Figure 3.12A). Efficient downregulation of Mib1 protein 
levels after KD was confirmed by WB analysis (Figure 3.12B). 
We next evaluated the roles of the endocytic proteins clathrin, dynamin2 and AP2 in our 
mammalian model system. Signaling by Delta, in D. melanogaster, can occur both by 
CME and CIE (Windler & Bilder, 2010), while in a mammalian context Dll1 signaling has 
been recently shown to be clathrin dependent (Meloty-Kapella, et al., 2012). As previously 
reported, dynamin is needed for Notch signaling both in the signal-sending and in the 
signal-receiving cell (Seugnet, et al., 1997). Conversely, recent evidence proposes that AP2 
is dispensable for Dll1 activity (Meloty-Kapella, et al., 2012). 
When we silenced the three proteins in OP9-Dll1 cells and performed the Notch reporter 
transactivation assay, we observed that Notch reporter activity was not inhibited upon AP2 
KD, but was significantly impaired upon KD of dynamin2 or clathrin heavy chain (CHC) 
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in OP9-Dll1 cells (Figure 3.13A). Efficient downregulation of AP2, dynamin2 and CHC 
protein levels after KD was confirmed by WB analysis (Figure 3.13B). 
Therefore our data are a confirmation that Dll1 endocytic activation might be mediated by 
a dynamin-dependent, clathrin-dependent AP2-independent pathway. Moreover we can 
conclude that the Notch reporter transactivation assay is also a suitable assay to investigate 
the contribution of endocytic players to Notch ligands activation in the signal-sending cell. 
 
	  
Figure 3.12 KD of Mib1 in the signal-sending cell reduces Notch activation in the Notch 
reporter transactivation assay. 
A. Mindbomb1 (Mib1) expression was silenced in OP9-Dll1 cells by lipofectamine transfection of 
specific siRNAs. Lipofectamine alone (Mock) or a negative control siRNA oligo (CTR) were used 
as controls for KD specificity. 48 hours after the second KD round, cells were co-cultured for 24 
hours with C2C12-Notch1 cells, transiently transfected with the Notch-reporter firefly luciferase 
construct and the renilla luciferase control construct, before measuring luciferase activity. The bar 
graph depicts the relative luciferase activity of the Notch-reporter firefly luciferase normalized to 






































the red line indicates 50% of the signal, to help visualize changes in luciferase activity. Values are 
expressed as the mean ± SEM. Three independent experiments were performed. Statistical 
significance between KD and CTR samples was calculated using the Student’s T-test: *** p < 
0.001.  
B. Efficiency of Mindbomb1 (Mib1) KD was assessed by WB analysis of the same samples shown 
in A. At the end of the co-culture, samples were lysed and proteins were extracted. Proteins were 
then separated by SDS-PAGE and blotted onto a nitrocellulose membrane. Specific antibodies, as 
indicated on the right, were used to probe the membrane. Vinculin was used as a loading control. 




Figure 3.13 KD of CHC and dynamin2 but not AP2 in the signal-sending cell reduces Notch 
activation in the signal-receiving cell. 
A. AP2, dynamin2 (Dyn2) or clathrin heavy chain (CHC) expression was silenced in OP9-Dll1 
cells by lipofectamine transfection of specific siRNAs. Lipofectamine alone (Mock) or a negative 
control siRNA oligo (CTR) were used as controls for KD specificity. 48 hours after the second KD 
round, cells were co-cultured for 24 hours with C2C12-Notch1 cells, transiently transfected with 































































measuring luciferase activity. The bar graph depicts the relative luciferase activity of the Notch-
reporter firefly luciferase normalized to the activity of renilla luciferase. The blue line indicates 100% 
of the CTR luciferase activity, while the red line indicates 50% of the signal, to help visualize 
changes in luciferase activity. Values are expressed as the mean ± SEM. Three independent 
experiments were performed. Statistical significance between KD and CTR samples was calculated 
using the Student’s T-test: *** p < 0.001.  
B. Efficiency of AP2, dynamin2 (Dyn2) or clathrin heavy chain (CHC) KD was assessed by WB 
analysis of the same samples shown in A. At the end of the co-culture, samples were lysed and 
proteins were extracted. Proteins were then separated by SDS-PAGE and blotted onto a 
nitrocellulose membrane. Specific antibodies, as indicated on the right, were used to probe the 
membrane. Vinculin was used as a loading control. Blot is representative of three repeats. 
 
4.2 Silencing Numb and Numb-like in the signal-sending cell does not reduce Notch 
transactivation 
As already described, Numb is a negative regulator of Notch activity in the signal-
receiving cell, both in D. melanogaster and in mammalians (Couturier, et al., 2012; 
Hutterer & Knoblich, 2005; McGill, et al., 2009; McGill & McGlade, 2003; Pece, et al., 
2004; Tang, et al., 2005). In the genesis of the Drosophila sensory organ, the precursor cell 
divides asymmetrically, generating two daughter cells with different fates, the pIIa and 
pIIb. This is due to asymmetric partitioning of Numb and its role as a negative regulator of 
the Notch receptor. However, endocytosis of Delta is also involved in pIIa/pIIb 
specification (Polo & Di Fiore, 2006). Considering these premises, we asked if Numb 
could also regulate the activity of the Notch ligands in the signal-sending cell. 
To address this question we silenced Numb and its homolog Numb-like in OP9-Dll1 cells, 
by lipofectamine transfection of specific siRNA oligos. We then co-cultured the cells with 
C2C12-Notch1 cells and performed the Notch reporter transactivation assay. As a positive 
control we used OP9-Dll1 cells in which Mindbomb1 KD had been performed (Figure 
3.14A). 
We observed that Notch reporter activity was not inhibited following KD of Numb and 
Numb-like, either singly or combined (Figure 3.14A). Since an antibody against Numb-
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like was not available, we confirmed the efficient downregulation of the mRNA levels 
after KD by QPCR analysis (Figure 3.14B-D). 
Based on these data we can conclude that neither Numb nor Numb-like have a role in the 
regulation of Notch ligands activity in the signal-sending cell. 
 
 
Figure 3.14 KD of Numb and Numb-like in the signal-sending cell does not reduce Notch 
transactivation 
A. Numb, Numb-like (N-L), combined Numb+Numb-like (Numb/N-L) or Mindbomb1 (Mib1) 
expression was silenced in OP9-Dll1 cells by lipofectamine transfection of specific siRNAs. A 
negative control siRNA oligo (CTR) was used as controls for KD specificity. 48 hours after the 
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transfected with the Notch-reporter firefly luciferase construct and the renilla luciferase control 
construct, before measuring luciferase activity. The bar graph depicts the relative luciferase activity 
of the Notch-reporter firefly luciferase normalized to the activity of renilla luciferase. The blue line 
indicates 100% of the CTR luciferase activity, while the red line indicates 50% of the signal, to 
help visualize changes in luciferase activity. Values are expressed as the mean ± SEM. Four 
independent experiments were performed. Statistical significance between KD and CTR samples 
was calculated using the Student’s T-test: *** p < 0.001.  
B-D. Efficiency of Numb (B), Numb-like (N-L) (C), combined Numb+Numb-like (Numb/N-L) (B-
C) or Mindbomb1 (Mib1) (D) KD, was assessed by QPCR analysis of the same samples shown in 
A. At the end of the co-culture, samples were lysed and total mRNA was extracted. The bar graph 
depicts the relative mRNA levels of the KD samples normalized on the CTR sample. Values are 
expressed as the mean ± SEM. Four independent experiments were performed. 
 
 
4.3 Silencing Eps15 and Eps15L1 in the signal-sending cell reduces Notch 
transactivation 
After verifying that the Notch reporter assay is able to detect alterations in the signal-
sending cell that affect Notch activation in the signal-receiving cell, we evaluated the 
effects of silencing Eps15 and Eps15L1 in OP9-Dll1 cells. To exclude siRNA off-target 
effects, we used three different siRNA oligonucleotides for each protein silenced: siRNAs 
51, 52 and 53 for Eps15 and siRNAs 54, 55 and 56 for Eps15L1. We observed an approx. 
50% reduction of Notch reporter activity after KD of Eps15 with all the three 
oligonucleotides tested and an approx. 40% reduction of Notch reporter activity after KD 
of Eps15L1 (Figure 3.15A). Western blot analysis confirmed the efficient silencing of 
Eps15 and Eps15L1 proteins, with all siRNA oligonucleotides used (Figure 3.15B). We 
subsequently repeated the co-culture assay with one single siRNA oligonucleotide for each 
protein silenced (52 for Eps15 and 54 for Eps15L1), and obtained consistent results (Figure 
3.17A).  
We also performed combined Eps15/Eps15L1 in OP9-Dll1 cells, and we observed that the 
combined KD did not further reduce the levels of Notch transactivation obtained by the 
KD of the single proteins (Figure 3.17A). 
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In conclusion these results indicate that Eps15 and Eps15L1 are necessary for the 
regulation of the Notch ligand Dll1 activity in the signal-sending cell. The results also 
suggest that the two proteins are not functionally redundant, but they both appear to have a 
critical function in Notch ligand regulation. 
 
 
Figure 3.15 Eps15 and Eps15L1 silencing in the signal-sending cell reduces Notch 
transactivation.  
A. KD of Eps15 (51, 52, 53) and Eps15L1 (54, 55, 56) was performed in OP9-Dll1 cells by 
lipofectamine transfection of specific siRNAs. Lipofectamine alone (Mock) or a negative control 
siRNA oligo (CTR) were used as controls for KD specificity. 48 hours after the second KD round, 
cells were co-cultured for 24 hours with C2C12-Notch1 cells, transiently transfected with the 
Notch-reporter firefly luciferase construct and the renilla luciferase control construct, before 
measuring luciferase activity. The bar graph depicts the relative luciferase activity of the Notch-
reporter firefly luciferase normalized to the activity of renilla luciferase. The blue line indicates 100% 















































changes in luciferase activity. Values are expressed as the mean ± SD and are the result of a single 
experiment.  
B. Efficiency of Eps15 and Eps15L1 KD was assessed by WB analysis of the same samples shown 
in A. At the end of the co-culture, samples were lysed and proteins were extracted. Proteins were 
then separated by SDS-PAGE and blotted onto a nitrocellulose membrane. Specific antibodies, as 
indicated on the right, were used to probe the membrane. Vinculin was used as a loading control. 
 
4.4 Silencing Epsin1 and Epsin2 in the signal-sending cell reduces Notch 
transactivation 
Epsin1 and Epsin2 are known to be key regulators of mammalian Dll1 (Meloty-Kapella, et 
al., 2012). Epsins are endocytic adaptor proteins that participate in CME and CIE together 
with Eps15 and Eps15L1 (Chen, et al., 1998; Sigismund, et al., 2005). Epsin1 and Epsin2 
have been proprosed, together with clathrin, to have a fundamental role in the regulation of 
Dll1 activation by endocytosis (Meloty-Kapella, et al., 2012). 
To investigate the involvement of Epsin1 and Epsin2 in activation of Notch signaling, we 
silenced their expression in the signal-sending OP9-Dll1 cells. Again, we used three 
different siRNA oligonucleotides (siRNAs 48, 49 and 50 for Epsin1 and siRNAs 67, 68 
and 69 for Epsin2) for each protein to guard against off-target effects. We observed that 
KD of Epsin1 and Epsin2 in OP9-Dll1 cells impaired Notch transactivation by about 
approx. 50% and 40%, respectively (Figure 3.16A). WB analysis confirmed the efficient 
KD of both proteins with all siRNA oligonucleotides used (Figure 3.16B). We 
subsequently repeated the Notch reporter transactivation assay silencing Epsin1 and Epsin2 
with one single siRNA oligonucleotide for each protein (48 for Epsin1 and 69 for Epsin2), 
and obtained consistent results (Figure 3.17A). 
As we did for Eps15/Eps15L1, we also performed combined Epsin1/Epsin2 KD in OP9-
Dll1 cells. Interestingly, similarly to what we observed for Eps15/Eps15L1, we could not 
score a further reduction in Notch reporter activity after combined Epsin1/Epsin2 KD 
compared to the single KDs (Figure 3.17A). 
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Figure 3.16 Epsin1 and Epsin2 silencing in the signal-sending cell reduces Notch 
transactivation.  
A. KD of Epsin1 (48, 49, 50) and Epsin2 (66, 67, 68) was performed in OP9-Dll1 cells by 
lipofectamine transfection of specific siRNAs. Lipofectamine alone (Mock) or a negative control 
siRNA oligo (CTR) were used as controls for KD specificity. 48 hours after the second KD round, 
cells were co-cultured for 24 hours with C2C12-Notch1 cells, transiently transfected with the 
Notch-reporter firefly luciferase construct and the renilla luciferase control construct, before 
measuring luciferase activity. The bar graph depicts the relative luciferase activity of the Notch-
reporter firefly luciferase normalized to the activity of renilla luciferase. The blue line indicates 100% 
of the CTR luciferase activity, while the red line indicates 50% of the signal, to help visualize 
changes in luciferase activity. Values are expressed as the mean ± SD and are the result of a single 
experiment.  
B. Efficiency of Epsin1 and Epsin2 KD was assessed by WB analysis of the same samples shown 
in A. At the end of the co-culture, samples were lysed and proteins were extracted. Proteins were 
then separated by SDS-PAGE and blotted onto a nitrocellulose membrane. Specific antibodies, as 
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4.5 Eps15/Eps15L1 and Epsin1/Epsin2 act in distinct pathways of Notch ligand 
activation 
Eps15/Eps15L1, together with Epsin1, regulate CIE of EGFR (Sigismund, et al., 2005). To 
understand if, similarly, a combined action of Eps15/Eps15L1 together with Epsin1/Epsin2 
might regulate Dll1 activity, and to determine whether these two protein families are acting 
in the same or distinct pathways leading to Notch ligand activation, we decided to perform 
the quadruple KD of Eps15/Eps15L1/Epsin1/Epsin2 in OP9-Dll1. 
Indeed, after the quadruple KD in OP9-Dll1 cells, we observed a complete block of Notch 
transactivation that was similar to the block observed following Mib1 KD (Figure 3.17A). 
Moreover, KD of any given combination of Eps15 or Eps15L1 with Epsin1 or Epsin2 
resulted in an almost complete loss of Notch transactivation (Figure 3.17A). WB analysis 
confirmed the efficient KD of all proteins (Figure 3.17B). 
Together, these data suggest that the Eps15 and Epsin protein families likely act in two 
distinct, non-redundant, pathways leading to activation of the Notch ligand Dll1. 
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Figure 3.17 Effect of combined Eps15/Eps15L1 and Epsin1/Epsin2 KDs in the signal-sending 
cell on Notch transactivation. 
A. Eps15 (15), Eps15L1 (L1), Eps15/Eps15L1 (15/L1), Epsin1 (E1), Epsin2 (E2), Epsin1/Epsin2 
(E1/2), Eps15/Epsin1 (15/E1), Eps15/Epsin2 (15/E2), Eps15L1/Epsin1 (L1/E1), Eps15L1/Epsin2 
(L1/E2), Eps15/Eps15L1/Epsin1/Epsin2 (Qdr) or Mindbomb1 (Mib1) expression was silenced in 
OP9-Dll1 cells by lipofectamine transfection of specific siRNAs. Lipofectamine alone (Mock) or a 
negative control siRNA oligo (CTR) were used as controls for KD specificity. 48 hours after the 
second KD round, cells were co-cultured for 24 hours with C2C12-Notch1 cells, transiently 
transfected with the Notch-reporter firefly luciferase construct and the renilla luciferase control 
construct, before measuring luciferase activity. The bar graph depicts the relative luciferase activity 



































































































indicates 100% of the CTR luciferase activity, while the red line indicates 50% of the signal, to 
help visualize changes in luciferase activity. Values are expressed as the mean ± SEM. At least 
three independent experiments were performed. Statistical significance between KD and CTR 
samples was calculated using the Student’s T-test: *** p < 0.001.  
B. Efficiency of KD was assessed by WB analysis of the same samples shown in A. At the end of 
the co-culture, samples were lysed and proteins were extracted. Proteins were then separated by 
SDS-PAGE and blotted onto a nitrocellulose membrane. Specific antibodies, as indicated on the 
right, were used to probe the membrane. Vinculin was used as a loading control. 
 
4.6 Eps15 and Eps15L1 silencing in the signal-sending cell has a similar impact on the 
activation of all Notch ligands  
The partial effect observed on Dll1 activity after combined KD of Eps15/Eps15L1 in our in 
vitro model system, does not explain the strong Notch-like phenotype displayed by 
Ep15/Eps15L1-DKO embyros (see Introduction Section 4.1-4.2). We therefore decided to 
perform a Notch transactivation assay to screen the other three Notch ligands, Dll4, Jag1 
and Jag2, to understand the contribution of Eps15/Eps15L1 to their activation. We 
obtained OP9 cells stably overexpressing Dll4, Jag1 or Jag2 (Van de Walle, et al., 2011). 
Eps15/Eps15L1 were silenced in these cells using siRNA oligo 51 and 52 for Eps15, and 
54 and 56 for Eps15L1, either singly or together. Data obtained with both siRNA oligos 
were consistent, and therefore pooled into figure 3.18. 
In all samples, we observed a similar reduction in Notch reporter activity as observed after 
KD of Eps15/Eps15L1 in OP9-Dll1 cells. Single KD of Eps15 or Eps15L1 inhibited Notch 
activity by approx. 50% and the double KD did not significantly increase the effect. Mib1 
KD was performed in each cell line as a positive control (Figure 3.18A-C). We confirmed 
the efficient downregulation of the target proteins, following KD, by WB analysis (Figure 
3.19).  
These data indicate that the mechanism of action of Eps15/Eps15L1 on Notch ligands 
regulation is likely conserved on all Notch ligands. 
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Figure 3.18 Eps15 and Eps15L1 have a similar role in the regulation of all Notch ligands. 
A-C. Eps15 (15), Eps15L1 (L1), Eps15/Eps15L1 (15/L1) and Mindbomb1 (Mib1) expression was 
silenced in OP9-Dll4 (A), OP9-Jag1 (B) or OP9-Jag2 (C) cells by lipofectamine transfection of 
specific siRNAs. Lipofectamine alone (Mock) or a negative control siRNA oligo (CTR) were used 
as controls for KD specificity. 48 hours after the second KD round, cells were co-cultured for 24 
hours with C2C12-Notch1 cells, transiently transfected with the Notch-reporter firefly luciferase 
construct and the renilla luciferase control construct, before measuring luciferase activity. The bar 
graph depicts the relative luciferase activity of the Notch-reporter firefly luciferase normalized to 
the activity of renilla luciferase. The blue line indicates 100% of the CTR luciferase activity, while 
the red line indicates 50% of the signal, to help visualize changes in luciferase activity. Values are 

































Mock CTR 15 L1 15/L1 Mib1











































significance between KD and CTR samples was calculated using the Student’s T-test: * = p < 0,05, 
**= p < 0,01, *** = p < 0,001.  
 
 
Figure 3.19 Efficiency of KD in OP9-Dll4, OP9-Jag1 and OP9-Jag2 cells. 
A-D. Efficiency of Eps15 and/or Eps15L1 (A-C), and Mib1 (D only) KD in OP9-Dll4 (A, D), OP9-
Jag1 (B, D) and OP9-Jag2 (C, D) cells was assessed by WB analysis of the same samples shown in 
Figure 3.18. At the end of the co-culture, samples were lysed and proteins were extracted. Proteins 
were then separated by SDS-PAGE and blotted onto a nitrocellulose membrane. Specific 
antibodies, as indicated on the right, were used to probe the membrane. Vinculin was used as a 


































































































4.7 Combined Eps15/Eps15L1 KD in both the signal-sending and signal-receiving cell 
does not further reduce Notch transactivation compared to combined KD in the 
signal-sending cell alone 
We next asked whether silencing of Eps15 and Eps15L1 at the same time in both the 
signal-sending and signal-receiving cell could unmask a further downregulation of Notch 
signaling and mimic the severe phenotype of the Eps15/Eps15L1 DKO mice in vitro. To 
address this question, we performed a Notch reporter transactivation assay after combined 
KD of Eps15/Eps15L1 in both OP9-Dll1 and C2C12-Notch1 cells and observed a similar 
reduction in Notch reporter activity as observed in OP9-Dll1 Eps15/Eps15L1 double KD 
cells alone (Figure 3.20). Thus, Notch activity was only partially inhibited and the 
combined KD in both signal-sending and signal-receiving cells did not significantly 
increase this effect. 
This result is consistent with our data showing no effect of Eps15/Eps15L1 KD in the 
signal-receiving cells and supports the notion that Eps15/Eps15L1 are important regulators 
of Notch ligand activation. However, we could not replicate in vitro a complete Notch loss 
of function phenotype due to the lack of Eps15/Eps15L1, indicating that even if the two 
endocytic adaptor proteins play an important role in the modulation of Notch ligand 
activation, probably impairment of other signaling pathways is involved in the severe 





Figure 3.20 Silencing of Eps15 and Eps15L1 in both the signal-sending and signal-receiving 
cell does not further reduce Notch transactivation. 
A. Eps15/Eps15L1 (15/L1) expression was silenced in OP9-Dll1 cells and C2C12-Notch1 cells by 
lipofectamine transfection of specific siRNAs. A negative control siRNA oligo (CTR) was used as 
controls for KD specificity. 48 hours after the second KD round, OP9-Dll1 cells were co-cultured 
for 24 hours with KD C2C12-Notch1 cells, transiently transfected with the Notch-reporter firefly 
luciferase construct and the renilla luciferase control construct, before measuring luciferase activity. 
The bar graph depicts the relative luciferase activity of the Notch-reporter firefly luciferase 
normalized to the activity of renilla luciferase. The blue line indicates 100% of the CTR luciferase 
activity, while the red line indicates 50% of the signal, to help visualize changes in luciferase 
activity. Values are expressed as the mean ± SEM. Four independent experiments were performed. 
Statistical significance between KD and CTR samples was calculated using the Student’s T-test: 
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5. Dll1 internalization is Eps15 and Eps15L1 independent 
5.1 Dll1 internalization assay setup and characterization 
In the previous chapter, we demonstrated that, in the signal-sending cell, both Eps15 and 
Eps15L1 are required to achieve efficient transactivation of Notch in the signal-receiving 
cell.  
Endocytosis is strictly required in the signal-sending cell to generate a ligand that is 
capable of activating the Notch receptor in the signal-receiving cell (Parks, et al., 2000; 
Seugnet, et al., 1997). Two non-mutually exclusive hypotheses have been formulated to 
explain the requirement for ligand endocytosis in Notch signaling: 
i) Notch ligands need to undergo endocytosis and recycling to be correctly processed 
and activated; 
ii) the endocytic pulling forces that are generated following ligand-receptor binding, 
generate a conformational change in the receptor, that promotes receptors activation. 
Since it is known that Epsins are key regulators of Notch ligand endocytosis (Meloty-
Kapella, et al., 2012; Wang & Struhl, 2004; Wang & Struhl, 2005), and since Eps15 and 
Eps15L1 are known to act in combination with Epsin1 to regulate EGFR CIE (Sigismund, 
et al., 2005), we asked whether Eps15 and Eps15L1 could also have a role in the regulation 
of Notch ligands internalization. 
To test this hypothesis, we first needed to set-up a Dll1 endocytosis assay in OP9-Dll1 
cells. Evidences from D. melanogaster literature indicate that Notch ligands can undergo 
two different types of endocytosis: i) constitutive endocytosis, that is independent of 
receptor binding, and ii) receptor-stimulated endocytosis, that occurs upon binding to the 
receptor. To follow constitutive Dll1 internalization, we used an anti-Dll1 antibody 
conjugated to an Alexa 647 fluorochrome. We chose this system because we reasoned that 
an antibody that binds to surface Dll1 would be internalized as the ligand undergoes 
constitutive endocytosis. To measure receptor-stimulated endocytosis of Dll1, we took 
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advantage of a Notch2-Fc recombinant protein that we preclustered with a secondary 
antibody conjugated to an Alexa 647 fluorochrome. Again, we reasoned that the 
preclustered Notch-Fc protein would bind to the Dll1 ligand, mimicking the interaction 
between ligand and receptor and allowing, in turn, clusterization of Dll1 in the plasma 
membrane. 
With these tools, we set-up a cytofluorimetry-based, quantitative, Dll1 internalization 
assay. OP9-Dll1 cells were detached from the plate by mild trypsinization, to avoid ligand 
loss. Anti-Dll1 antibody (to follow constitutive internalization) or preclustered Notch-Fc 
(to follow receptor-mediated internalization), were added to the cell suspension at 37°C. 
Dll1 internalization was performed at 37°C. At different time-points (2, 4 and 6 minutes) 
internalization was stopped on ice, and samples were treated or not with pronase, to 
remove all Dll1 present on the membrane and therefore to determine respectively the 
internalized quote of Dll1 and the total amount of Dll1 (internalized+bound). Samples 
were quantified by cytofluorimetry analysis. The bound quote of Dll1 was then calculated 
subtracting the internalized Dll1 value from the total Dll1 value (Figure 3.21). 
	  
Figure 3.21 Schematic representation of the Dll1 internalization assay in OP9-Dll1 cells. 
The cartoon schematically depicts the main passages of the Dll1 internalization assay protocol. 
OP9-Dll1 cells in suspension were treated either with a preclustered N2Fc recombinant protein or 
with an antibody anti Dll1. Internalization was performed at 37°C; at different timepoints (2, 4 and 
6 minutes) internalization was stopped and samples were treated (Internalized) or not (Total) with 
pronase. Samples were quantified by cytofluorimetry analysis. 
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By plotting the internalized/bound ratio against time (as a y = mx equation), we were able 
to calculate the endocytic rate constant (Ke), which is a cellular constant that defines the 
probability of a receptor to be internalized in 1 minute at 37°C (Wiley & Cunningham, 
1982). The endocytic rate constant (Ke) was extrapolated from the internalization curves 
and corresponds to the slope (m) of the best-fitting curve.  
As expected, we observed that the Ke for constitutive internalization of Dll1 (0.0385) is 
lower than the Ke for receptor-mediated internalization of Dll1 (0.1195) in OP9-Dll1 cells 
(Figure 3.22), indicating that constitutive internalization in a slower process than receptor-
mediated internalization. Interestingly, the Ke for receptor-mediated internalization of Dll1 
is in line with the published value of the ligand induced Ke of EFGR (0.185), following 
binding with EGF at physiological concentrations (i.e. 1ng/ml), measured in murine 
embryonic fibroblasts NIH 3T3 (Sorkin & Duex, 2010).  
Taken together these observations suggest that the Dll1 internalization assay could 
approximately mimic the physiological conditions at which endocytosis of a membrane 
bound protein occurs. 
 
Figure 3.22 Receptor-mediated and constitutive internalization of Dll1 in OP9-Dll1 cells. 
Line graph comparing the ratio of internalized/surface-bound Dll1 after receptor-mediated 
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OP9-Dll1 cells at 2, 4 and 6 minutes of internalization at 37°C. Three independent experiments 
were performed, a representative one is shown here. The endocytic rate constant Ke (slope) is 
shown next to each line. 
 
5.2 Dll1 internalization assay validation and characterization 
To validate the two Dll1 internalization assays, we decided to assess the effects of 
silencing Mib1 or CHC on both receptor-mediated and constitutive internalization of Dll1. 
We observed that receptor-mediated internalization of Dll1 was almost completely 
abolished after Mib1 KD and significantly inhibited after CHC KD (Figure 3.23A), 
consistent with a model in which binding of Notch to Dll1 leads to Dll1 ubiquitination and 
subsequent internalization (Itoh, et al., 2003; Lai, et al., 2005; Song, et al., 2008). In 
contrast, constitutive endocytosis of Dll1 was not affected by CHC KD and was reduced 
by 50% by Mib1 KD (Figure 3.23B). This result suggests that constitutive internalization 




Figure 3.23 Effect of Mib1 and CHC silencing on receptor-mediated and constitutive 
endocytosis of Dll1 in OP9-Dll1 cells. 
A-B. Mindbomb1 (Mib1), or clathrin heavy chain (CHC) expression was silenced in OP9-Dll1 
cells by lipofectamine transfection of specific siRNAs. A negative control siRNA oligo (CTR) was 
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the plate and the cytofluorimetry-based internalization assay was performed as described in 
methods.  
A. The bar graph depicts the endocytic rate constants for receptor-stimulated internalization of 
Dll1. The red line indicates 100% of the signal, while the blue line indicates 50% of the signal, to 
help visualize changes. Values are expressed as the mean ± SEM. Four independent experiments 
were performed. Statistical significance between KD and CTR samples was calculated using the 
Student’s T-test: ** = p < 0.01, *** = p < 0.001. 
B. The bar graph depicts the endocytic rate constants for constitutive internalization of Dll1. The 
red line indicates 100% of the signal, while the blue line indicates 50% of the signal, to help 
visualize changes. Values are expressed as the mean ± SEM. Four independent experiments were 
performed. Statistical significance between KD and CTR samples was calculated using the 




5.3 Dll1 surface levels in OP9-Dll1 after KD of Eps15 and Eps15L1 are not altered 
Internalization is considered a “first-order kinetics” process. Therefore, the rate of 
internalization depends on the concentration of receptor-ligand complexes at the cell 
surface (Sorkin & Duex, 2010). In the case of Dll1 internalization, the endocytic rate 
constant Ke would be dependent on the amount of Dll1 protein at the membrane at any 
given time point. Therefore, to compare changes in the Ke following different treatments, 
it is necessary to assess that the levels of Dll1 protein at the membrane are comparable in 
all the samples. 
To take this variable into account, before measuring the effects of Eps15/Eps15L1 KD on 
Dll1 internalization, we measured surface levels of Dll1 in steady state OP9-Dll1 cells after 
KD of Eps15 and Eps15L1. We also evaluated the effects of Mib1,clathrin and Epsin1 KD, 
to control for previous and future experiments.  
To measure Dll1 surface levels, we stained OP9-Dll1 cells in suspension, with an antibody 
anti Dll1 conjugated to an Alexa 647 fluorochrome. We then quantified the samples by 
cytofluorimetry analysis. 
We observed that Eps15, Eps15L1 and the combined Eps15/Eps15L1 KD did not alter 
Dll1 surface levels in steady state OP9-Dll1 cells (Figure 3.24). Similarly, CHC KD had no 
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effect, while Epsin1 KD and Mindbomb1 KD resulted in a small but significant increase in 
Dll1 at the cell surface (Figure 3.24). Combining Eps15 with Epsin1 KD did not show any 
change in Dll1 surface levels compared to Epsin1 KD alone (Figure 3.24).  
Taken together these observations suggest that it will be possible to compare Ke rates for 
all the samples, taking in consideration the differences observed in theMindbomb1 and 
Epsin1 samples. 
Since the endocytic rate constant depends on the internalized/bound ratio, an increase in 
Dll1 levels at the membrane should result in an increased bound value, therefore a 
decreased Ke. On the other hand, a decrease in the internalization rate of a membrane 
bound protein should lead to increased surface levels of the same protein, consistent with 
an endocytic block. In the case of the results shown above for Mindbomb1 KD, however, 
the reduction that we observe in the Ke value can be only partially ascribed to the 
increased Dll1 levels, since amount of reduction in the Ke is not mirrored by the same 
amount of increase in Dll1 levels.  
 
	  
Figure 3.24 Surface levels of Dll1 after KD in OP9-Dll1 cells at steady state 
Eps15 (15), Eps15L1 (L1), Eps15/Eps15L1 (15/L1), Epsin1 (E1), Mindbomb1 (Mib1), clathrin 
heavy chain (CHC) and Eps15/Epsin1 (15/E1) expression was silenced in OP9-Dll1 cells by 
lipofectamine transfection of specific siRNAs. A negative control siRNA oligo (CTR) was used as 
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and Dll1 surface levels were measured by cytofluorimetry analysis.	  The bar graph depicts the mean 
fluorescence corresponding to Dll1 protein levels at the membrane at steady state. Values are 
expressed as the mean ± SEM. Four independent experiments were performed. Statistical 
significance between KD and CTR samples was calculated using the Student’s T-test: * = p < 0,05. 
 
 
5.4 Loss of Eps15 and Eps15L1 does not affect receptor-mediated or constitutive Dll1 
internalization 
After validating the internalization assays and controlling the effects of silencing of 
proteins of interest on surface levels of Dll1, we proceeded to evaluate the effect of 
Eps15/Eps15L1 KD on Dll1 receptor-mediated and constitutive internalization. We 
performed both single and combined KDs of Eps15 and Eps15L1 and observed that none 
of these KDs affected Dll1 internalization, either receptor-stimulated or constitutive 
(Figures 3.25A and B). However, when we performed KD of Epsin1, we scored a 
significant inhibition of receptor-stimulated internalization of Dll1, but not of constitutive 
internalization (Figures 3.25A and B). A small decrease in the Ke rate following Epsin1 
KD was expected, according to the measured increase in Dll1 surface levels. However, as 
in the case of Mindomb1, the reduction that we observe in the Ke value of stimulated Dll1 
internalization (50%) can be only partially ascribed to the increased Dll1 levels. Taken 
together, these results are in line with published data showing that Epsin1 is a fundamental 
player in Notch ligand internalization (Meloty-Kapella, et al., 2012). When we then 
combined Eps15/Epsin1 KD, we observed the same effect as Epsin1 alone (Figure 3.25A).  
In conclusion these findings indicate that Eps15 and Eps15L1 are not involved in the early 
steps of Dll1 internalization, either alone or in conjunction with the Epsins. 
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Figure 3.25 Eps15 and Eps15L1 do not have a role in internalization of the Notch ligand Dll1. 
A-B. Eps15 (15), Eps15L1 (L1), Eps15/Eps15L1 (15/L1), Epsin1 (E1), and Eps15/Epsin1 (15/E1) 
expression was silenced in OP9-Dll1 cells by lipofectamine transfection of specific siRNAs. A 
negative control siRNA oligo (CTR) was used as control for KD specificity. 48 hours after the 
second KD round, cells were detached from the plate and the cytofluorimetry-based internalization 
assay was performed as described in methods.  
A. The bar graph depicts the endocytic rate constants for receptor-stimulated internalization of 
Dll1. The red line indicates 100% of the signal, while the blue line indicates 50% of the signal, to 
help visualize changes. Values are expressed as the mean ± SEM. Four independent experiments 
were performed. Statistical significance between KD and CTR samples was calculated using the 
Student’s T-test: *** = p < 0,001. 
B. The bar graph depicts the endocytic rate constants for constitutive internalization of Dll1. The 
red line indicates 100% of the signal, while the blue line indicates 50% of the signal, to help 
visualize changes. Values are expressed as the mean ± SEM. Four independent experiments were 
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6. Investigating the role of Eps15 and Eps15L1 in Dll1 recycling 
6.1 Dll1 recycling to the cell surface after internalization does not occur in OP9-Dll1 
cells in suspension 
It is well accepted that Notch ligands, at least in some contexts, need to go through a 
recycling process in order to be activated. The precise role of this recycling step is still 
unknown; some speculate that the ligand needs to be recycled in order to go through an 
unknown post-translational modification, while others speculate that recycling is needed to 
relocalize the ligand to specific membrane compartments, known as lipid rafts (Hamel, et 
al., 2010; Heuss, et al., 2008; Heuss, et al., 2013; Wang & Struhl, 2004; Windler & Bilder, 
2010).  
Since Eps15 has previously been ascribed a role in EGFR recycling (Chi, et al., 2011), we 
wanted to test whether Eps15 and Eps15L1 might also be involved in Dll1 recycling. As a 
first approach, we decided to analyze Dll1 recycling from a quantitative point-of-view, 
employing a fluorescence-based recycling assay. To set-up this recycling assay, we 
adapted the Dll1 internalization assays described in Results Section 5 to measure the 
amount of internalized Dll1 ligand that is recycled to the cell surface. OP9-Dll1 cells were 
detached from the plate by mild trypsinization.  Dll1 internalization was performed, 
following the addition of preclustered NFc to the cells, at 16°C for 1 hour. At this 
temperature, recycling is impaired (Ren et al., 1998), resulting in accumulation of ligand in 
the cytoplasm. Internalization was stopped on ice, and all samples were treated with 
pronase, to remove all Dll1 present on the membrane. Cells were shifted to 37°C for up to 
30 minutes to stimulate Dll1 recycling. Treatment with cyclohexamide was used to inhibit 
de novo protein synthesis thereby avoiding export of newly synthesized proteins to the 
plasma membrane. The amount of recycled Dll1 was then determined by surface staining 
at 4°C with an anti Dll1 Alexa647; the recycled Dll1 quote was the quantified by 
cytofluorimetric analysis (Figure 3.26). 
 117 
	  
Figure 3.26 Schematic representation of the Dll1 recycling assay in OP9-Dll1 cells. 
The cartoon schematically depicts the main passages of the Dll1 recycling assay protocol. 
Following receptor-mediated internalization at 16°C for 1 hour (to impair recycling and accumulate 
the protein in the cytoplasm), OP9-Dll1 cells in suspension were treated treated with pronase to 
deplete the quote of Dll1 still on the membrane. OP9-Dll1 cells were afterwards released at 37°C to 
allow recycling. Samples were then stained at 4°C with an anti Dll1 Alexa 647, and the recycled 
Dll1 quote was quantified by cytofluorimetric analysis.	  
	  
	  
To set-up the assay, we initially monitored the rate of receptor-dependent Dll1 
internalization at 16°C. OP9-Dll1 cells were incubated with preclustered NFc at 16°C for 
up to 4 hours. At various time points, the amount of membrane-bound vs. internalized Dll1 
was measured as previously described in section 5.1. We observed a steady decrease in 
surface Dll1, accompanied by an increase in internalized Dll1, over time, with 
approximately 80% of Dll1 protein internalized by 4 hours (Figure 3.27A).  
Having verified an efficient internalization of Dll1 at 16°C, we then measured Dll1 
recycling. After stimulating Dll1 internalization at 16°C for 1 hour, cells were shifted to 
37°C for up to 30 minutes, and the amount of recycled Dll1 determined, both in the 
presence and absence of cyclohexamide. We observed that, after 30 minutes, only 6% of 
the internalized Dll1 was recycled back to the cell surface (Figure 3.27B). This result 
contrasts with published data which shows that Dll1 recycling in OP9-Dll1 cells is a rapid 
process, with almost all internalized Dll1 being recycled back to the plasma membrane 
after 15 – 30 minutes incubation at 37°C (Heuss, et al., 2008). 
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To exclude that the Notch-Fc complexes prevented detection of the recycled Dll1, we also 
performed a recycling assay following Dll1 constitutive internalization. However, we 
observed no recycling when we performed Dll1 internalization either with the anti-Dll1 
antibody or without any antibody.  
Taken together, these results suggest that Dll1 recycling may not occur in OP9-Dll1 cells 
in suspension. Therefore, to assess the role of Eps15/Eps15L1 in Dll1 recycling a change 
of strategy is necessary. In particular we will try to perform a biotinilation-based assay on 
adherent OP9-Dll1 cells, as described by (Heuss, et al., 2008). 
 
Figure 3.27 Dll1 recycling to the cell surface after internalization does not occur in OP9-Dll1 
cells in suspension. 
A. Efficiency of receptor mediated Dll1 internalization at 16°C. OP9-Dll1 cells in suspension 
were incubated with preclustered N2Fc at 16°C for 30, 60, 120, 180 and 240 minutes. The amount 











































cytofluorimetric analysis. Two independent experiments were performed: a representative one is 
shown here.  
B. Dll1 recycling to the cell surface after receptor-mediated internalization. OP9-Dll1 cells in 
suspension were incubated with preclustered N2Fc at 16°C for 1 hour. After treatment with 
pronase, cells were incubated for 2, 5, 10 and 30 minutes at 37°C, to allow Dl1 recycling. The 
graph shows the amount of recycled Dll1 in the presence (white rhombus) or absence (black 
triangle) of cyclohexamide, as quantified by cytofluorimetric analysis. Two independent 




7. Assessing the role of Eps15 and Eps15L1 in Dll1 membrane 
localization in OP9-Dll1 cells 
7.1 Dll1 is predominantly located in lipid rafts in OP9-Dll1 cells 
In addition to the quantitative approach to assess Dll1 recycling, we also assessed recycling 
from a qualitative point-of-view, looking at localization of Dll1 in plasma membrane lipid 
rafts. 
To determine whether Eps15/Eps15L1 have a role in directing Dll1 to lipid microdomains, 
we first set-up the experimental conditions for identifying the location of proteins in 
different membrane fractions. We decided to perform a biochemical purification of 
detergent-resistant membrane (i.e., lipid rafts) in a sucrose gradient according to (Heuss, et 
al., 2008) and (Shah, et al., 2012) with modifications. We lysed OP9-Dll1 cells in a lysis buffer 
containing Brij58 detergent. We then fractionated 200 µg of cell lysates by 
ultracentrifugation in a 5 – 30% continuous sucrose gradient. The distribution of Dll1 in 
the different fractions was then analyzed by WB. We observed, in two independent 
experiments, that Dll1 was enriched in fractions 7 and 8 (Figure 3.28). As a marker for 
lipid raft localization, we used caveolin1, which was enriched in fractions 7, 8, 9 and 10. 
We also assayed our fractions for EGFR, a receptor known to be localized in lipid rafts 
(Abulrob et al., 2004; Mineo et al., 1999; Yamabhai & Anderson, 2002), and found that it 
was enriched in the same fractions as Dll1 (Figure 3.28). As a negative control for lipid 
rafts, we used tubulin, which has been employed as a marker for cytoplasmic fractions. 
Tubulin was detected in the first 6 fractions of the gradient. Together, these results confirm 
a lipid raft localization of Dll1 in OP9-Dll1 cells and indicate that our purification protocol 




Figure 3.28 Purification of lipid rafts with Brij58 in OP9-Dll1 cells. 
A-B. WB analysis of two independent biochemical purifications of detergent resistant membrane in 
a 5 – 30% continuous sucrose gradient. OP9-Dll1 cells were lysed in a Brij58 containing lysis 
buffer. 200 µg of total protein lysate were loaded on the gradient and utracentrifugated for 16 hours 
at 4°C at 37000 rpm in a swing out 55ti rotor. At the end of centrifugation, 13 fractions were 
collected (each fraction with a total volume of 400 µl) and then 30 µl of each fraction were 
separated by SDS-PAGE and blotted onto a nitrocellulose membrane. 2 µg (WCE 1/100) and 4 µg 
(WCE 1/50) of whole cell exctract (WCE) were loaded on gel as positive controls. Specific 






















7.2 Eps15 and Eps15L1 silencing in OP9-Dll1 cells does not alter Dll1 localization in 
lipid rafts 
Next, we assessed the effect of silencing of Eps15 and Eps15L1 in OP9-Dll1 on the 
localization of Dll1 in lipid rafts. We observed that in the control, Dll1 was enriched in 
fractions 7 and 8, while caveolin1 was enriched in fractions 7, 8 and 9 (Figure 3.29A), as 
observed in untreated cells (Figure 3.28A-B). This distribution did not change upon Eps15 
or Eps15L1 single KD, nor upon Eps15/Eps15L1 double KD (Figures 3.29B-D). The 
distribution of caveolin, tubulin and the EGFR were also unchanged (Figures 3.29B-D). 
Together, these results suggest that Eps15/L1 are not necessary for the localization of Dll1 
into lipid microdomains. 
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Figure 3.29 Eps15 and Eps15L1 KD in OP9-Dll1 cells does not alter Dll1 localization in lipid 
rafts. 
A-D. WB analysis of OP9-Dll1 cell lysates after a biochemical purification of detergent-resistant 














































(B), Eps15L1 (C), Eps15/Eps15L1 (D), was performed in OP9-Dll1 prior to the experiment. A 
negative control oligo CTR (A) was used as a control for KD specificity. For each condition, 200 
µg of total protein lysate, extracted in a Brij58 containing lysis buffer, were loaded on the sucrose 
gradient and utracentrifugated for 16 hours at 4°C at 37000 rpm in a swing out 55ti rotor. At 
the end of centrifugation, 13 fractions were collected (each fraction with a total volume of 400 µl) 
and then 30 µl of each fraction was separated by SDS-PAGE and blotted onto a nitrocellulose 
membrane. 2 µg (WCE 1/100) and 4 µg (WCE 1/50) of whole cell exctract (WCE) were loaded on 
gel as positive controls. Specific antibodies, as indicated on the right, were used to probe the 
membranes. Blots are representative of two independent experiments. 
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Chapter 4  
DISCUSSION 
 
In this work, we show that the endocytic adaptor proteins Eps15 and Eps15L1 play a 
critical role in the regulation of Notch signaling, acting at the level of the signal-sending 
cell. Several observations had previously suggested a role for Eps15 and Eps15L1 in the 
endocytic regulation of Notch signaling, such as their interaction with the endocytic 
adaptors, and Notch regulators, Epsin and Numb (Chen, et al., 1998; Salcini, et al., 1997). 
However, the first data directly linking the two proteins to Notch regulation came from the 
analysis of Eps15/Eps15L1 DKO mice (see Introduction Section 4.1). Morphological 
analysis of Eps15/Eps15L1 DKO embryos revealed severe developmental defects, similar 
to those observed in several Notch loss-of-function KO mice, such as Notch1-KO 
(Limbourg, et al., 2005; Swiatek, et al., 1994), Notch1/Notch4-DKO (Krebs, et al., 2000), 
Dll11-KO (Hrabe de Angelis, et al., 1997) and Epsin1/Epsin2-DKO (Chen, et al., 2009). 
Indeed, a defect in Notch signaling in Eps15/Eps15L1 DKO mice was confirmed by gene 
expression microarray analysis of 9.5-day-old DKO embryos, which revealed that the 
Notch target genes Hes1, Hes5 and NRAP were downregulated (see Introduction Section 
4.2). 
Employing an in vitro co-culture assay consisting of C2C12-Notch1 signal-receiving cells 
in co-culture with OP9-Dll1 signal-sending cells, we have now obtained direct evidence of 
an Eps15 and Eps15L1 involvement in Notch signaling regulation. We found that Eps15 
and Eps15L1 do not act as regulators of the Notch1 receptors, but instead participate in the 
regulation of the Notch ligands, Dll1, Dll4, Jagged1 and Jagged2. In contrast to the known 
role of Eps15 and Eps15L1 as endocytic adaptor proteins involved in CME and CIE of the 
EGFR (Benmerah, et al., 1998; Carbone, et al., 1997; Sigismund, et al., 2005), the 
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regulatory role that the two proteins exert on Notch ligands does not occur during the early 
steps of Dll1 endocytosis. Our data further suggest that Eps15 and Eps15L1 do not act 
together with the endocytic proteins Epsin1 and Epsin2 in regulating Notch ligand 
signaling, but rather through a distinct mechanism, possibly export to the plasma 
membrane or recycling.  
 
1. Advantages and pitfalls of our in vitro model system 
To be able to obtain direct proof of Eps15 and Eps15L1 regulation of Notch signaling, we 
needed to set-up an in vitro model system of Notch transactivation. In vitro models present 
both advantages and disadvantages compared to their in vivo counterparts. In vivo models 
are complex and recapitulate the biology of an entire organism, with its flexibility and 
adaptability to environmental changes and stimuli. In vitro systems are in contrast 
reductionist models, which, on the one hand, is an advantage, as they allow the analysis of 
specific pathways in the simplest system possible, and, on the other hand, a disadvantage, 
as they reduce the complexity of the organism to a single condition, which might not be the 
most representative one. 
In the case of Notch signaling, in particular, it is essential to work with a model system 
composed of a signal-sending cell and a signal-receiving cell, since both ligands and 
receptors are transmembrane proteins that need to undergo endocytosis and processing to 
become fully activated (Baron, 2012; Bray, 2006; Fortini, 2009; Kopan & Ilagan, 2009). 
For this reason, treating signal-receiving cells with a soluble extracellular domain of the 
ligand to activate Notch receptor, as has already been described (Hicks et al., 2002), does 
not recapitulate physiological Notch activation.  
However, a difficulty often encountered when working with a Notch signaling co-culture 
model system, is to be able to dissect effects in the signal-sending cell from effects in the 
signal-receiving cell. In vivo, the distinction between signal-sending and signal-receiving is 
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even more unclear, since very few cell populations express only Notch ligands or Notch 
receptors, as in the case of marginal zone B cells (Saito et al., 2003; Sheng et al., 2008; 
Song, et al., 2008; Tanigaki et al., 2002). The same is true also for in vitro systems, since 
the majority of cell lines express both Notch ligand and Notch receptors. Thus, in setting 
up a co-culture model system, it is essential to determine the expression profiles of cells 
before deciding in favor of particular cell models. The inability to dissect signal-sending 
effects from signal-receiving effects can lead to misinterpretation of the data since the 
mechanism of cis-inibition that Notch ligands operate over Notch receptors works as a 
molecular switch that can make cells shift between a state of signal-sending and signal-
receiving (Miller et al., 2009; Sprinzak, et al., 2010). 
Another critique that can be directed to Notch in vitro model systems is that they are 
composed of only one or two cell types. In contrast, in the organism, Notch signaling is 
active in numerous cellular compartments and can be differentially regulated according to 
the tissue specificity of the compartment. This gives rise to different biological outcomes 
of Notch signaling, such as proliferation, lineage commitment or terminal differentiation, 
in different cell types (Perdigoto & Bardin, 2013). 
When screening the literature to find a good model to recapitulate Notch signaling in vitro, 
we looked for a physiologically relevant system that would not only allow us to perform 
biochemical assays, but could also be used to perform biological assays, such as 
differentiation assays. Given the above considerations, we chose a co-culture system 
between two different cell lines: OP9-Dll1 as the signal-sending cell that expresses the 
Notch ligand Dll1, and C2C12 as the signal-receiving cell that expresses Notch receptors. 
The OP9-Dll1 model system was generated in 2002 by Schmitt and Zuniga-Pflucker; the 
expression of the Notch ligand Dll1 in the OP9 stromal cell line allowed, through an in 
vitro culture system, the generation of mature T cells from fetal liver stem cells (de Pooter 
& Zuniga-Pflucker, 2007; Holmes & Zuniga-Pflucker, 2009; Schmitt & Zuniga-Pflucker, 
2002). C2C12 is a mouse skeletal muscle cell line, subclone of the murine myoblast cell 
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line established by Yaffe and Saxel (Yaffe & Saxel, 1977), that is able to differentiate and 
form myotubes in vitro (Bains et al., 1984; Lawson & Purslow, 2000). Moreover, it has 
been demonstrated that ligand-induced Notch signaling can inhibit C2C12 myoblast 
differentiation (Nofziger et al., 1999; Shawber et al., 1996).  
Although the OP9-Dll1 and C2C12 cell lines are widely employed by scientists, we could 
not find data in the literature describing the expression of Notch ligands and receptors in 
these cells. Therefore, before proceeding with the co-culture assay, we verified, by Taqman 
technology, the mRNA profile of all Notch ligands and receptors in these cells. We 
confirmed that OP9-Dll1 cells express mainly Notch ligands with negligible amounts of 
Notch receptor transcript. In contrast, C2C12 cells do not express Notch ligand transcripts, 
but express detectable levels of endogenous Notch2 receptor mRNA. However, the level of 
Notch2 transcript was insufficient to produce an optimal signal upon activation. Notch 
activation was also not improved when we transiently transfected C2C12 cells with a 
construct encoding the Notch1 receptor. To overcome this difficulty, we decided to 
generate a stable cell line expressing the human receptor Notch1 and from this population 
we selected several clones. This was done to avoid working with a mass population 
expressing different levels of Notch receptor, therefore preventing the introduction of 
further variability to the assay. After testing the clones, we chose the one that yielded the 
best signal to noise ratio after ligand activation. In doing so, we accepted both advantages 
and disadvantages of working with a clonal cell line. In a clonal cell line, all cells derive 
from the same parental cell, meaning that all cells in the population will behave similarly 
when subjected to a stimulus. However, with a clonal cell line, we lose the intrinsic 
variability of a cell population and we risk amplifying casual mutations that could have 
been generated in the parental cell during the subcloning and amplification process. 
To validate our model system we performed several controls: 
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i) treatment with γ-secretase inhibitor DAPT confirmed that the signal detected with 
the Notch reporter transactivation assay can be indeed ascribed to Notch activation and 
not to a different pathway; 
ii) silencing of the Notch regulators Numb and dynamin in C2C12 cells confirmed 
respectively increased activation of the reporter gene, consistent with a removal of 
inhibition of the Notch receptor, and downregulation of the reporter gene, consistent 
with a block in Notch receptor endocytosis and consequent S2 cleavage; 
iii) downregulation of the Notch ligand regulator Mindbomb1 in OP9-Dll1 cells 
completely inhibited activation of the reporter, consistent with a block in ubiquitin-
mediated internalization of the ligand Dll1. 
Taken together, these observations on the behavior of the main players involved in Notch 
signaling regulation are an indication that the co-culture system we chose appears to be an 
appropriate model system to study Notch activation in vitro.  
 
 
2.Eps15 and Eps15L1 regulate Notch signaling in the signal-sending cell 
When we reasoned about a possible role of Eps15 and Eps15L1 in the regulation of Notch 
signaling, we hypothesized different mechanisms of actions. First, it is known that Eps15 
and Eps15L1 interact with both Numb and Epsin, two fundamental regulators of Notch 
signaling in the signal-receiving and signal-sending cell, respectively. Consequently, it was 
possible that Eps15 and Eps15L1 could carry out their role in combination with these 
Notch regulators, either modulating the activity of Notch receptors through their 
interaction with Numb or modulating internalization of the Notch ligands through 
interaction with Epsin1. Another possibility was that Eps15 and Eps15L1 might regulate 
Notch signaling via a novel mechanism that is not related to their interactors, Numb and 
Epsin. 
 130 
To assess if indeed Eps15 and Eps15L1 do have a direct role in the regulation of Notch-
signaling and to dissect if this possible regulation occurs in the signal-sending or in the 
signal-receiving cell, we performed the Notch reporter transactivation assay in our 
C2C12/OP9-DLL1 co-culture model system. 
We could not detect any role of Eps15 and Eps15L1 in the regulation of Notch receptors in 
the signal-receiving cell. In contrast, we detected alterations of reporter signal when we 
depleted Eps15 and Eps15L1 in the signal-sending cell. In particular, Notch signaling was 
downregulated by 40 – 50% after Eps15 or Eps15L1 KD in the signal-sending cell. 
Moreover, we were able for the first time to rule out, in a mammalian context, a role of the 
endocytic adaptor Numb in the regulation of Notch ligand in the signal-sending cell. Thus, 
we could exclude the possibility that Eps15 and Eps15L1 are acting in combination with 
Numb in the regulation of Notch ligand. 
Interestingly, simultaneous removal of both Eps15 and Eps15L1 in the signal-sending cell 
did not further reduce Notch signaling compared to removal of the single proteins. This 
result suggests that Eps15 and Eps15L1 are both critical components of the same pathway 
regulating Notch ligands. It is possible to speculate that the two proteins may have a 
redundant role in the regulation of Notch ligand and that a certain amount of total Eps15 
family proteins, irrespective of which, is required to carry out the correct function (Figure 
4.1). This hypothesis, namely “gene dosage hypothesis”, has already been suggested in the 
case of Epsin1 and Epsin2 in the regulation of Notch ligands (Meloty-Kapella, et al., 2012). 
Indeed, when we performed KD of Epsin 1 and 2 in our model system, we observed the 
same behavior that we observed following Eps15 and Eps15L1 KD: i.e. the double KD 
was similar to the single KDs, with no further decrease of transactivation signaling. To 
verify this gene dosage theory in our model system, it would be necessary to rescue 
Eps15L1 KD with overexpression of Eps15, or vice versa, to understand if a certain 
quantity of the Eps15 protein, no matter if it is Eps15 or Eps15L1, is needed to obtain an 
optimal Notch signaling (Figure 4.1). 
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Figure 4.1 The gene dosage hypothesis 
Cartoon depicting the gene dosage hypothesis applied to Eps15 and Eps15L1 in the regulation of 
Notch ligand signaling. The presence of Eps15 and Eps15L1 in the signal-sending cell gives rise to 
a fully functional Notch ligand, able to activate Notch signaling. Removal of either Eps15 or 
Eps15L1, or of both proteins, completely inactivates the pathway, giving rise to a semifunctional 
Dll1. Overexpression of Eps15 (or vice versa) gives rise to the minimal levels of protein required 
for Dll1 activation, therefore rescuing Dll1 activation. 
 
When we subsequently deleted Eps15 and Eps15L1 in combination with Epsin1 and 
Epsin2, we scored a complete inhibition of Notch signaling. We can explain this with two 
different hypotheses.  
i) The first hypothesis that we formulated is that Eps15 and Eps15L1 might have the 
same role as Epsin1 and Epsin2 in the regulation of Notch ligands, mediating their 
internalization, possibly in two parallel pathways. Consequently if abolishing the 
Eps15/Eps15L1-mediated route leads to a 50% reduction of the signal, and abolishing 
the Epsin1/Epsin2-mediated route leads again to a 50% reduction of the signal, it could 

























abrogated. Of course, this hypothesis only holds true if removal of one protein of the 
family completely destroys the pathway that the family is mediating. However, our 
results from the Dll1 internalization assay (discussed in section 3) disproved this 
hypothesis, showing that indeed Eps15 and Eps15L1 do not have a role in the 
regulation of Notch ligands endocytosis.  
ii) The second hypothesis that we formulated to explain these results, is that Eps15 and 
Eps15L1 could act by regulating a completely different process in ligand activation 
from Epsin1 and Epsin2, i.e. not internalization. Consequently, when both processes, 
internalization mediated by Epsin1/2 and the unknown process mediated by eps15/L1, 
are impaired by the loss of the four proteins, Notch ligands lose all ability to signal. 
Further evidences about the regulatory process that might be mediated by Eps15 and 
Eps15L1 will be detailed in section 3 and section 4. 
Since in D. melanogaster the two ligands Delta and Serrate appear to be regulated by 
different mechanisms (Wang & Struhl, 2004; Wang & Struhl, 2005), we were interested to 
explore whether Eps15 and Eps15L1 are able to regulate all mammalian Notch ligands. To 
do this, we tested, in our in vitro assay, not only the ligand Dll1, but also the ligands Dll4, 
Jagged1 and Jagged2. The impairment of Notch signaling after depletion of Eps15 and 
Eps15L1 in the signal-sending cell was similar for all ligands tested, indicating that the 
mechanism of action of the two endocytic proteins is conserved for all Notch ligands. 
Subsequently, we investigated if contemporary loss of Eps15 and Eps15L1 in both the 
signal-sending and the signal-receiving cell could uncover a further downregulation of 
Notch signaling, due to a cross-talk between the two cells. However, our KD experiments 
in both the signal-sending and the signal-receiving cell ruled out that possibility, further 
confirming that Eps15 and Eps15L1 do not indeed have any role in the regulation of the 
Notch receptors. 
At this point, it became clear that the data that we obtained in our in vitro study are 
partially incongruent with our in vivo model system of Eps15/Eps15L1 DKO mice. In fact, 
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the Eps15/Eps15L1 DKO mouse has a stronger phenotype compared to that of the Eps15 
and Eps15L1 single KO mice. In contrast, in the in vitro model system, removal of the 
single proteins had the same effect as removal of both. 
To explain this partial incongruence, two different hypotheses come to mind:  
i) First, it is possible that the partial additivity observed in vivo might be due to a 
higher flexibility of the organism (compared to an in vitro system) that, in the case of a 
single KO, is able to compensate for the loss of either Eps15 or Eps15L1, possibly 
through the upregulation and recruitment of other endocytic players. These 
compensatory mechanisms may come into play in the animal over time. Therefore they 
are not present when acute silencing of Eps15 and Eps15L1 is performed in our in vitro 
model system, where we uncover the loss-of-function phenotype already by removing 
one of the two players.  
ii) Second, it is possible that the phenotype of the Eps15/Eps15L1 DKO mice is the 
result of alterations of different signaling pathways, not just the Notch pathway. 
Alterations in these pathways may not have been detected by the microarray analysis, 
because they might not be due to transcriptional alterations, but to altered 
internalization/trafficking of receptors, such as the EGFR. In this case, the KO mice 
would have only a partial Notch phenotype. In support of this hypothesis, the extent of 
downregulation of Notch target genes in the Eps15/Eps15L1 DKO mice amounted to a 
50% reduction, comparable with the data obtained with our in vitro transactivation 
assay after silencing of either Eps15 or Eps15L1. Moreover, the extent of Notch target 
gene downregulation was similar in both the Epsin1/2 and Eps15/Eps15L1 DKO 
embryos, and Epsin1/2 and Eps15/L1 KD had comparable effects in our Notch reporter 
transactivation assay. Therefore it might be safe to speculate that additional Notch-
independent mechanisms may contribute to the phenotype of both Epsin1/2 and 
Eps15/Eps15L1 DKO mice. 
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3. Investigating Dll1 endocytosis and recycling 
To test whether Eps15 and Eps15L1 have a role in modulating Notch ligand endocytosis, 
we decided to set-up a quantitative, FACS-based, assay, to assess both receptor-stimulated 
and constitutive endocytosis of Dll1.  
We simulated receptor-induced endocytosis using a recombinant NotchFc protein, 
preclustered with a secondary antibody, in order to mimic receptor clusters on the signal-
receiving cell. We followed constitutive endocytosis by treating the cells with a 
fluorochrome-conjugated antibody, anti-Dll1 (Heuss, et al., 2008; Le Borgne et al., 2005; 
Meloty-Kapella, et al., 2012; Shah, et al., 2012). Dll1 receptor-mediated internalization 
stimulated with soluble NotchFc receptor might not recapitulate all aspects of Dll1 
endocytosis mediated by membrane-bound receptor. However, the validation of our assay 
set-up, performing KD of endocytic proteins that are known to regulate the Notch ligands 
endocytosis both in mammalians and in D. melanogaster, would suggest that with our in 
vitro assay we mimic as close as possible the in vivo physiological condition. 
Based on results from our Dll1 internalization assays, we could reject the hypothesis that 
Eps15 and Eps15L1 participate in the regulation of Notch ligand early endocytic events. 
Moreover, we excluded that Eps15 and Eps15L1 act in combination with their interactor 
Epsin1 in this regulatory process, as the combined Eps15/Epsin1 KD did not further reduce 
Dll1 endocytic rate, compared to Epsin1 alone. Thus, it appears that Eps15 and Eps15L1 
act at a different step in the ligand activation process that is not connected to early steps of 
internalization. 
Having concluded that Eps15/L1 are unlikely to be involved in internalization of Dll1, we 
decided to proceed by assessing whether Eps15 and Eps15L1 regulate Dll1 recycling. Dll1 
recycling can be investigated either: i) quantitatively, by measuring the amount of Dll1 
present at the plasma membrane; or ii) qualitatively, by assessing the localization of Dll1 
in specific plasma membrane microdomains. 
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We tried to first assess the recycling quantitatively, using a modified version of the 
internalization assay that we had previously set-up. However, we observed that Dll1 
recycling did not occur in our model system under our experimental conditions. This could 
be due to the fact that recycling was assessed on cells in suspension, and it is possible 
instead that recycling requires anchorage to the substrate and polarization of the cell. It has 
long been known in fact that anchorage-dependent cells (i.e. cells that need to be attached 
to a substrate in order to grow and proliferate) undergo a block in transcription and cell 
cycle when kept in suspension (Assoian & Zhu, 1997; Reddig & Juliano, 2005; Schulze et 
al., 1996), and it might be tempting to speculate that also recycling might undergo a similar 
block. For this reason, we have decided to use a biotinylation-based recycling assay, 
performed on adherent cells (Heuss, et al., 2008). Membrane proteins will be biotinylated, 
internalized and recycled to the plasma membrane. After cell lysis, pulldown of 
biotinylated proteins will be performed, and recycled Dll1 will be detected via western blot 
analysis. This assay, however, measures recycling only after constitutive internalization of 
Dll1. We are particularly interested in measuring recycling following Dll1 binding to 
Notch, since, from data on EGFR regulation, it appears likely that Eps15 and Eps15L1 act 
in a context of “ligand-induced” trafficking. Indeed, Eps15 and Eps15L1 mediated 
internalization of EGFR occurs after the receptor binds EGF, and receptor internal 
trafficking is determined by ligand concentration (Sorkin & Goh, 2008; Tomas et al., 2014). 
Moreover, Eps15 and Eps15L1 both possess two UIM, and since it is known that Dll1 is 
ubiquitinated, it is possible to speculate that Eps15/Eps15L1 regulation over Dll1 might be 
ubiquitin-mediated, and thus tightly regulated. In order to check these hypotheses, we will 
test whether it is feasible to perform the biotinylation-based recycling assay following 
Notch2Fc stimulated internalization of the ligand. 
To assess Dll1 recycling qualitatively, we decided to perform a lipid raft extraction after 
KD of Eps15 and Eps15L1 in the signal-sending cell. This experiment was highly 
reproducible and consistent with pubblished data (Heuss, et al., 2008; Heuss, et al., 2013; 
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Shah, et al., 2012). Moreover, when we tested EGFR localization as a control, we found it 
was localized within the lipid raft enriched fractions, as described in the literature (Abulrob, 
et al., 2004; Mineo, et al., 1999; Yamabhai & Anderson, 2002). However, we did not 
observe any changes in Dll1 localization at the membrane after removal of Eps15 and 
Eps15L1. This result suggests that the two proteins do not have a role in the export of 
Notch ligands to lipid rafts. 
 
4. Other possible mechanisms through which Eps15 and Eps15L1 could 
regulate Notch signaling and future directions 
When considering what other mechanisms involved in Dll1 activation could be regulated 
by Eps15 and Eps15L1, different hypothesis come to mind. 
First, we can consider hypotheses based on the roles already proposed in the literature for 
Eps15. For example, it might be possible that Eps15 and Eps15L1 are involved in Notch 
ligand degradation, since they are already known to participate in the regulation EGFR 
degradative pathway (Kostaras, et al., 2013; Roxrud, et al., 2008). However, it seems 
improbable that Eps15/Eps15L1 mediate degradation of Notch ligands, since when we 
analyzed Dll1 levels at the membrane after Eps15 and Eps15L1 KD, we did not score any 
changes. Nevertheless, it might still be possible that Dll1 levels at the membrane are more 
tightly regulated than intracellular levels, meaning that the cell might employ 
compensatory pathways to keep Dll1 levels at the membrane as constant as possible. To 
assess this point, it will be necessary to investigate total levels of Dll1 in OP9-Dll1 cells 
after depletion of Eps15 and Eps15L1. If a change in total levels is confirmed, we could 
perform a Dll1 degradation assay to further investigate the involvement of Eps15/L1 in this 
process. 
Another possibility is that Eps15 and Eps15L1 could act as regulators of the Dll1 
biosynthetic pathway, in particular controlling its trafficking through the Golgi apparatus, 
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as they already do for EGFR and Coronin7 (Chi, et al., 2008; Yuan, et al., 2014). If 
Eps15/L1 were to have a regulatory role in the Dll1 secretory pathway, then depletion of 
the two proteins should give rise to a delay in the Dll1 export. However, we observed that 
steady state levels of Dll1 at the plasma membrane do not change after Eps15 and Eps15L1 
KD, suggesting that this scenario is unlikely. Alternatively, we could speculate that an 
incorrect trafficking through the Golgi could lead to an incorrect glycosylation of Dll1, 
resulting in a less active ligand. To test the first hypothesis, we could perform an imaging 
assay that allows us to monitor the Dll1 biosynthesis over time, whereas, for the second 
hypothesis we could perform a mass spectrometry analysis to assess glycosylation. 
A more unbiased screen that we could perform to understand the molecular mechanism of 
Eps15 and Eps15L1 in the regulation of Notch ligands, is a structure/function analysis to 
rescue the phenotype obtained in the Notch reporter transactivation assay using different 
Eps15 mutants. In particular, we could employ: 
i) the Eps15 point mutant L883A that abolishes both binding to ubiquitin and the 
ability of Eps15 to be ubiquitinated (Woelk et al., 2006); Notch ligands are in fact 
known to be ubiquitinated and both their internalization and their degradation is 
ubiquitin-mediated;  
ii) the Eps15 mutant Δ14aa, that lacks the 14 amino acids responsible for AP1 
binding (Chi, et al., 2008); AP1 is involved in the formation of clathrin-coated 
vesicles in the trans-Golgi network secretory pathway, therefore the Δ14aa mutant 
could give us an indication about the role of Eps15 and Eps15L1 in the export of 
Dll1 to the plasma membrane; 
iii) the two Eps15 isoforms, Eps15b or Eps15s, which lack the EH or the UIM 
domains, respectively (Chi, et al., 2011); Eps15b is known to mediate the sorting 
of the EGFR towards the degradative pathway, while Eps15s is involved in the 
recycling of the internalized EGFR back to the cell surface. 
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Finally, we cannot exclude the possibility that the effect of Eps15 and Eps15L1 on Notch 
signaling might be of a more indirect nature. There are in fact different several factors that 
could have an indirect effect on signaling, such as cell morphology, cell adhesion to the 
substrate, cell polarity, cell proliferation or cell-cell interaction. In the case of Eps15 and 
Eps15L1, it is known that they regulate trafficking of occludin, a component of tight 
junctions (Murakami, et al., 2009). Tight junctions are epithelial cell-cell junctions located 
between the apical and basolateral portions of the plasma membrane within cells. They 
function as a barrier to regulate the paracellular passages of molecules; moreover they limit 
the movement of lipids and proteins between the apical and the basolateral portions of the 
membrane and more recently have been implicated in the control of cell proliferation and 
gene expression (Gonzalez-Mariscal et al., 2008). Eps15and Eps15L1, moreover, have 
been shown to regulate the internalization of connexin43, a component of gap junctions 
(Girao, et al., 2009). Gap junctions are intercellular membrane channels composed by 
connexin monomers; they regulate the aqueous exchanges between the cytoplasm of 
contiguous cells and in doing so they allow the exchange of ions, nucleotides, small 
molecules and second messengers (Saez & Leybaert, 2014). Several studies also suggest 
that connexin43 hemichannels contribute to the regulation of signaling induced by 
mechanical stress in bone tissues (Buo & Stains, 2014). Finally Eps15 has also been shown 
to regulate internalization of integrin β1, through its binding with the endocytic adaptor 
Dab2 (Teckchandani, et al., 2012). Integrins are transmembrane receptors that act as 
bridges for cell-cell and cell-extracellular matrix interactions. Integrins also regulate 
intracellular signaling pathways and cooperate to promote cell growth, cell survival, and 
cell proliferation. Moreover integrins have been reported to directly regulate Notch 
signaling (Estrach et al., 2011; Gomez-Lamarca et al., 2014; Stenzel et al., 2011). 
Taken together, all these observations suggest that the role of Eps15 and Eps15L1 in the 
cell is complex and multifaceted, raising the possibility that they do not directly regulate 
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